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ABSTRACT 
Wagner, Jennifer L. Ph.D., Purdue University, December 2013. Effects of 
Coadministration of D-Napvsipq [NAP] and D-Sallrsipa [SAL] on Spatial Learning After 
Developmental Alcohol Exposure. Major Professor: Charles Goodlett. 
Despite warnings about the dangers of drinking during pregnancy, little progress has been 
made in reducing alcohol drinking among women of childbearing age. Even after the 
recognition of pregnancy, 15% of women continue to drink, 3% of which admit to binge 
drinking. Because we cannot stop women from drinking during pregnancy, and many 
children with fetal alcohol spectrum disorders (FASD) are adopted, there is a significant 
need to develop postnatal interventions that can improve the long-term outcome of 
children adversely affected by prenatal alcohol exposure. This thesis aims to evaluate one 
promising new treatment in the rehabilitation or rescue of specific learning deficits long 
after the damage has occurred.  
 
The treatment evaluated herein (40µg D-NAP + 40µg D-SAL) has long been used in the 
prevention of the detrimental effects of long-term and binge-like alcohol exposures in 
rodent models of fetal alcohol syndrome and FASD. Until recently this peptide treatment 
had only been shown to be effective in preventing some of the consequences of alcohol 
exposure when administered concurrently with the prenatal alcohol exposure. A recent 
report by Incerti and colleagues (2010c), however, reported that these peptides could 
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completely reverse a profound spatial learning deficit induced by one episode of a heavy 
binge-like alcohol exposure (5.9g.kg in a single intraperitoneal injection) on gestational 
day 8 (G8) in C57BL/6 mice. In that report, the peptide treatment was administered 
starting in late adolescence, beginning three days prior to and throughout water maze 
training, and the profound deficits in their alcohol-placebo group were completely 
eliminated in the alcohol-peptide group. There are currently no FDA-approved treatments 
for FASD. An effective treatment for the cognitive and behavioral dysfunctions suffered 
by the 1% of people born today could potentially improve the lives of millions of 
children and adults.  
 
The first aim of this thesis was to determine whether the peptide treatment could reverse 
the significant spatial learning deficits we have demonstrated in adult C57BL/6 mice 
given high-dose binge-like alcohol exposure (2.5 g/kg in each of two intraperitoneal 
injections separated by two  hours) on postnatal day (P)7. When administered three days 
prior to and throughout water maze testing (P67-76), the peptide treatment had no effect 
on spatial learning.  
 
The second aim sought to determine whether the same peptide treatment could reverse 
water maze spatial learning deficits in G8 binge-like exposure models, as reported by 
Incerti et al. (2010c). For this analysis, the first study used a different binge-like alcohol 
exposure model that is more commonly used than that employed by the Incerti et al. 
(2010c) study, namely administration of 2.8g/kg in each of two intraperitoneal injections 
separated by four hours (Sulik et al., 1981). This model has been shown to produce high 
viii 
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peak blood alcohol concentrations and neuroanatomical aberrations in the hippocampal 
formation and septal regions (Parnell et al., 2009), which have been implicated in 
learning and memory. Surprisingly, this G8 binge-like alcohol exposure failed to produce 
a spatial learning deficit, undermining the usefulness of this model in evaluating the 
peptide effects. In direct contrast to the outcomes of Incerti et al. (2010c), the G8 Webster 
alcohol exposure was also unable to produce any deficits in acquisition of spatial learning 
in the Morris water maze.  
 
Surprisingly, neither of the heavy binge-like alcohol exposures on G8 were able to 
produce spatial learning deficits in the Morris water maze. The binge-like alcohol 
exposure on P7 did yield the expected spatial learning deficit, but the peptide treatment 
was unsuccessful in recovering water maze learning. These findings fail to support oral 
administration of 40µg D-NAP and 40 µg D-SAL as a potential therapy for postnatal 
alcohol-induced spatial learning deficits in adult mice. 
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CHAPTER 1 INTRODUCTION 
1.1 Introduction 
Despite 50 years of research documenting the consequences of gestational alcohol 
exposure, there are currently no FDA-approved treatments for fetal alcohol syndrome 
(FAS) or fetal alcohol spectrum disorder (FASD). Therefore, the search for therapeutic 
interventions for the cognitive and behavioral deficits associated with gestational alcohol 
exposure is a priority (Warren and Foudin, 1994). 
 
In animal model studies, the neuropeptides D-NAPVSIPQ and D-SALLRSIPA, referred 
to hereafter as D-NAP and D-SAL, respectively, have been shown to be effective in both 
the prevention and recovery of gestational alcohol-induced impairments in fetal growth 
and development when administered concurrently (Zhou et al., 2008, Incerti et al., 2010a, 
Spong, 2006, Spong et al., 2001). In addition, offspring given heavy binge alcohol on 
gestational day 8 (G8) then given oral peptide treatment administered three days prior to 
and overlapped with behavioral testing in late adolescence completely recovered spatial 
learning deficits (Incerti et al., 2010c). Despite the growing reports on the efficacy of the 
combined peptide treatment on different aspects of alcohol-induced perturbations of 
neural development (Sari et al., 2013, Sari et al., 2011, Sari, 2009), the mechanisms by 
which these treatments benefit alcohol-affected offspring remains elusive. The goal of the 
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present study was to determine whether the efficacy of the peptide treatment was specific 
to the particular timing of the alcohol insult (e.g. gestational vs. neonatal exposure).  
 
The studies outlined in this thesis will attempt to answer whether or not combined 
administration of the peptides D-NAP and D-SAL can reverse spatial learning deficits in 
the adult mouse induced by developmental alcohol insults. Specifically, two separate 
time periods in human gestation were targeted; the fourth week of human gestation (G8 
in mice) and the later portion of the third trimester (roughly 34 weeks in humans or P7 in 
mice).  
 
1.2 Fetal Alcohol Spectrum Disorder 
1.2.1 Background 
Maternal alcohol use has long been associated with negative neurobehavioral deviations 
from normal human development. One historical account of the evils of drinking during 
pregnancy comes from the Old Testament, “[T]hou shalt conceive and bear a son. Now 
therefore beware, I pray thee, and drink not wine nor strong drink and eat not any unclean 
thing (Judges, 13:3-4).” Fetal alcohol syndrome (FAS) was first coined as a term in 1973 
when patterns of malformations were noted in 8 unrelated children of alcoholic mothers 
spanning three different ethnic groups (Jones et al., 1973). However, these same patterns 
of anomalies were actually published five years earlier in an obscure French journal by a 
French pediatrician who had compiled over a hundred of cases of children born to 
alcoholics (Lemoine et al., 1968). Outside the clinic, references to the dangers of 
consuming alcohol during pregnancy have become commonplace in today’s society, with 
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warnings posted on bottles, in bars, liquor stores and anywhere alcohol is sold across the 
nation. However, despite significant efforts in publicizing the damage of alcohol drinking 
during pregnancy and the expansion of public awareness, nearly 15% of women continue 
to drink after recognition of pregnancy, 3% of which binge drink (NIAAA, 2008).  
 
1.2.2 Fetal Alcohol Spectrum Disorder Epidemiology 
For decades, researchers have documented the long-term irreversible neuroanatomical, 
behavioral and cognitive dysfunctions in children exposed to alcohol during gestation. 
Yet, it is the distinctive craniofacial dysmorphology (smooth or indistinct philtrum, thin 
vermillion border, and small palpebral fissures), microcephaly or other central nervous 
system (CNS) abnormalities, and growth retardation that are required for the clinical 
diagnosis of FAS, the most severe diagnosis, along the spectrum of FASD (Hoyme et al., 
2005). The prevalence of FAS has been estimated to be as high as 0.33 to 2.2 per 1,000 
live births in the United States (Abel and Sokol, 1991, May and Gossage, 2001, Stratton 
et al., 1996), reaching as high as 2-7 per 1,000 within populations of mixed racial and 
socioeconomic status (May et al., 2009). Lacking the facial dysmorphology required for a 
diagnosis of FAS does not preclude cognitive and behavioral dysfunction associated with 
gestational alcohol exposure. Therefore, individuals who were exposed to alcohol during 
gestation but who fail to meet the criteria FAS, usually because they do not have full 
facial dysmorphology, may be classified as partial FAS (PFAS), alcohol-related 
neurodevelopmental disorders (ARND) and alcohol related birth defects (ARBD), which 
together fall under the umbrella term FASD. As shown in Figure 1, classification as 
PFAS requires a history of heavy maternal alcohol consumption during pregnancy, two 
  
4 
4
 
of the three previously mentioned facial characteristics, small head circumference, and 
growth retardation or cognitive/behavioral dysfunction. The term ARND is reserved for 
children with significant cognitive and/or behavioral impairment, but lacking the 
distinctive craniofacial abnormalities necessary for a classification as FAS or PFAS.  
 
Figure 1.2.1  Graphical representation of the differential diagnostic criteria for Fetal 
Alcohol Spectrum Disorders. (adapted from Stratton et al., 1996) 
 
The term fetal alcohol spectrum disorder (FASD) was coined as an umbrella term to 
define the continuum of consequences in children exposed to alcohol during gestation. 
Many children exposed to alcohol prenatally suffer similar neuropsychological and 
behavioral deficits, without the facial features necessary for a diagnosis of FAS (Mattson 
et al., 1998b). As such, the incidence of this more comprehensive category of gestational 
alcohol-induced impairments was estimated at 9-10 per 1,000 live births here in the US 
(May and Gossage, 2001, Sampson et al., 1997), but was recently updated to be as high 
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as 2-5% of younger school children in the US and Western Europe using active case 
ascertainment methods with in-school populations (May et al., 2009). 
 
1.2.3 Economic Impact of FASD 
Roughly 4 million people are born in the US each year (Ventura et al., 2003), and, of 
those, approximately 40,000 suffer from the neurobehavioral consequences of maternal 
alcohol consumption during pregnancy. The enormous economic impact caring for an 
additional 40,000 cognitively impaired individuals each year can have on society is 
calculated using estimates that factor in health impacts and associated care and services, 
criminal justice costs, and loss of productivity, as well as indirect factors, such as 
administrative, policy and research costs to name a few. The annual cost of FAS in the 
US has been estimated to be between $3.6 and $4 billion (Lupton et al., 2004, Olson et al., 
2009). In a Canadian study, Stade and colleagues (2009) reported that the average annual 
cost per individual with FASD is $21,642, with an annual cost for all individuals with 
FASD estimated to be $5.3 billion. 
 
1.2.4 Peripheral Clinical Issues Associated with Gestational Alcohol Exposure 
Toxicity of alcohol to the developing fetus has effects on other organ systems beyond the 
central nervous system. Alcohol exposure during the periconceptional period has been 
associated with an increased risk of skeletal, urogenital and congenital heart defects, 
specifically conotruncal heart defects (Grewal et al., 2008, Burd et al., 2007, Tsukahara 
and Kajii, 1988, Pauli and Feldman, 1986), which typically involve the improper 
separation of the chambers of the heart, or the major blood vessels leaving the heart. 
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Numerous studies report hepatic, renal and gastrointestinal abnormalities in children 
exposed to alcohol in utero (for review see: Stratton et al., 1996); however, consistent 
abnormalities in either of the organ systems have not been identified (Hofer and Burd, 
2009).  In addition to the distinctive patterns of craniofacial dysmorphology of FAS, 
children prenatally exposed to alcohol have been found to have an increased incidence of 
cleft lip, with or without cleft palate (Grewal et al., 2008). While these defects are 
substantial and detrimental, their incidence is vastly overshadowed by the 
neuropsychological and behavioral dysfunctions of FASD. 
 
1.2.5 Behavioral Dysfunction Associated with FASD 
Gestational alcohol exposure is considered the leading cause of preventable mental 
retardation. While diminished intellectual capacity is a pronounced sequela of FASD, 
attentional deficits (Fernandez et al., 1983, Shaywitz et al., 1980, Caul et al., 1979, 
Landesman-Dwyer et al., 1978, Nanson and Hiscock, 1990, Richardson et al., 2002, 
Streissguth et al., 1986) and hyperactivity (Mattson and Riley, 1998, Shaywitz et al., 
1980, Caul et al., 1979, Streissguth et al., 1978, Kelly et al., 1987b) are also prominent. 
Hyperactivity is present with such consistency that elevated activity levels have been 
suggested to be a more accurate phenotypic index of alcohol-induced teratogenicity than 
the craniofacial dysmorphology required for an FAS diagnosis (Shaywitz et al., 1980, 
Landesman-Dwyer et al., 1981). Hyperactivity and attentional deficits have been 
described as being “Hallmark Features of Prenatal Alcohol Exposure” (Mattson and 
Riley, 1998) and can occur in the absence of obvious intellectual deficits. Thus, it is 
possible that children diagnosed with disorders of hyperactivity and attention may 
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actually represent a subset of children with symptoms of FASD that may be under 
diagnosed (Steinhausen, 1996, Mattson et al., 2013, Ware et al., 2013). Coles (2001) 
suggests that this misclassification could be due to the conventional attention deficit 
hyperactivity disorder (ADHD) diagnostic model which utilizes behavioral checklists and 
parent and teacher ratings to infer attentional dysfunction. However, using standardized 
tests to evaluate the four factors of attention: sustain, shift, encode and focus; children 
with FAS or PFAS show a much different behavioral profile than those with ADHD 
without gestational alcohol exposure (Coles et al., 1997). While ADHD children have 
severe deficits in focusing and sustaining attention, children with gestational alcohol 
exposure show deficits in encoding and shifting attention (Coles et al., 1997). 
 
1.2.6 Executive Functioning Deficits Associated with FASD 
Children with FASD go mostly unrecognized until challenged in school (Streissguth et al., 
1990, Brown et al., 1991). Some deficits, including spatial learning and memory, 
response inhibition, dyscalcula and psychosocial functioning, have been noted to be more 
severe in individuals with greater reported prenatal alcohol exposure (O'Connor et al., 
1986, Coles et al., 1991, Streissguth et al., 1989, Jacobson et al., 2008, Coles et al., 2009) 
and have been shown to become more apparent with age (Streissguth et al., 1991, 
Streissguth et al., 1994). The behavioral profile of children and adults with FAS or FASD 
includes impairments on experimental tests of executive function such as the Wisconsin 
Card Sorting and Stroop tasks, Controlled Oral Word Association, Word Context tests 
and spatial learning and memory as measured by the Trail Making task (Connor et al., 
2000, Kodituwakku et al., 1995, Mattson et al., 1999). Deficits in abstract thinking, 
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cognitive flexibility and working memory measured by the Progressive Planning Test and 
California Tower Task have further alluded to executive impairment. Verbal learning and 
auditory memory are often reported to be impaired in children with FASD (Mattson et al., 
1999, Olson et al., 1998, Burden et al., 2005, Mattson et al., 1996, Mattson et al., 1998b, 
Uecker and Nadel, 1998, Hamilton et al., 2003, Kodituwakku et al., 1995, Mattson et al., 
1998a, Aragon et al., 2008, Schonfeld et al., 2001). The Delis-Kaplan Executive Function 
System (DKEFS) is a set of performance-based tasks designed to measure the executive 
functioning of individuals between the ages of 8 and 89 (Delis et al., 2001). Children with 
confirmed prenatal alcohol exposure, 60% of which met Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV) criteria for ADHD, were found to be impaired on 
all measures of executive function measured by the DKEFS, including the Verbal 
Fluency-Switching, Design Fluency-Switching, Trail Making Test-Switching, and Color-
Word Interference-Inhibition/Switching tasks. Interestingly, subjects with confirmed 
alcohol exposure were not found to be different than children with ADHD on these tasks 
(Ware et al., 2012). Deficits in executive functioning tasks, collectively, illustrate 
impairments in higher-order cognitive functioning governed by the prefrontal cortex.  
Impairments in attentional set shifting, planning and visual motor integration often lead 
to difficulty processing complex, hierarchical stimuli impairing higher-order cognitive 
functioning especially in this population (Kodituwakku, 2007). This underscores the 
importance of advancing the understanding of the influence of developmental alcohol 
exposure on higher-order executive functions that impact the quality of daily life in those 
with FASD.  
 
  
9 
9
 
A common tool used to evaluate domains of daily functioning, communication, social 
and motor skills is the Vineland Adaptive Behavioral Scale (VABS). The VABS is a 
parent/caregiver rating form in which behavioral questions are assessed as never, 
sometimes or partially, and usually occurring; and scored as 0-2 respectively. Adults with 
FAS assessed with the VABS have been found to show impairment in normal maturation 
of social skills (Streissguth et al., 1991, LaDue et al., 1992). Adolescent children with 
FASD have also been found to display more aggression and have more externalizing 
problems as reported by teachers, an effect that was more pronounced in children 
exposed throughout gestation rather than those whose mothers stopped drinking in the 
third trimester of pregnancy (Brown et al., 1991).  
 
In contrast to measures of executive functioning, adolescents with confirmed alcohol 
exposure are reported to be significantly more impaired than children with an ADHD 
diagnosis, but no confirmed alcohol exposure, on the VABS. Some studies have found 
younger children with confirmed alcohol exposure to be less or not at all impaired on the 
VABS (Coles et al., 1991), while other studies have found severe deficits in social skills 
of FAS children using the same scales (Thomas et al., 1998). However, there were major 
differences in the populations evaluated in these two studies. The study by Thomas and 
colleagues (1998) evaluated those with confirmed alcohol exposure, but more typical IQ 
scores, where as Coles and colleagues (1991) evaluated lower socioeconomically-
challenged, alcohol-abusing population. Despite the disparate findings using the VABS, 
anecdotal reports within the literature base lend validity to the idea that social deficits 
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may become more reliably apparent or more disruptive with the increased social 
interaction that comes with age.  
 
Children with FAS have been known to make bad decisions resulting in increased 
probability of delinquency, criminality, and combative behavior, have difficulties in work 
performance, and demonstrate deficits in response inhibition (Streissguth et al., 1997). 
Taken together, this information provides insights into social disturbances and response 
inhibition in children with FASD, suggesting that those affected by FASD may have an 
underlying increase in impulsivity that may be mediating attentional deficits and learning 
disabilities.  
 
Despite clinical findings suggesting fetal alcohol exposure leads to problems with 
impulse control, systematic preclinical studies of the mechanisms of gestational alcohol 
exposure on impulsive choice behavior have yet to be conducted. These faulty decision-
making strategies can lead to losses of productivity in ones working life and add more 
direct economic costs such as criminal activity and processing through the justice 
department. 
Spatial Learning and Memory 
Decades of animal research have led to an extensive literature base describing the 
alcohol-induced damage to the hippocampal formation and correlated spatial learning 
deficits (Gianoulakis, 1990, Zimmerberg et al., 1991, Goodlett and Peterson, 1995, 
Johnson and Goodlett, 2002, Blanchard et al., 1987, Goodlett et al., 1989b). Similarly, 
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children with FAS are found to be deficient on tasks that involve spatial recall. For 
example, children shown a book of pictures in sets of four can correctly identify pictures 
previously seen versus new pictures, but can not remember the spatial relationship of 
missing pictures to others that were previously shown on the same page (Uecker and 
Nadel, 1998).  
 
Another task that has been shown to be one of the more sensitive to the effects of prenatal 
alcohol exposure is the stepping stone task.  This task requires children to navigate a 
matrix of stones to find an invisible path through both a short and long version. 
Adolescents with FAS have also shown deficits in this more complex spatial learning 
task that requires both short-term memory and spatial learning. Specifically, children 
exposed to alcohol gestationally require significantly more trials to reach their first 
success and make more errors than unexposed controls (Streissguth et al., 1994).  
 
More recently, researchers have adapted a commonly used task to evaluate spatial 
learning in rodents for use in children and adults. Using a computerized version of the 
Morris water maze, children are asked to navigate a virtual environment to locate a 
hidden platform (Hamilton et al., 2002). Over trials, humans learn to navigate direct paths 
to the hidden platform using distal cues. However, patients with compromised neural 
circuitry involving the hippocampus or neighboring substrates show deficits in task 
performance (Astur et al., 2002, Maguire et al., 1999). Likewise, children with a history 
of gestational alcohol exposure show a significant impairment in place learning in the 
virtual water maze (Hamilton et al., 2003).  
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1.2.7 Summary 
FASDs affect nearly one percent of live births in the Western world. Despite years of 
research documenting the damage caused by gestational alcohol exposure and the great 
efforts used to curb alcohol drinking among pregnant women, no measurable progress 
has been made in reducing risky drinking in this population. As such, work to reduce the 
behavioral deficits like hyperactivity and attention deficits, as well as the cognitive 
effects like impulsivity, planning difficulties and spatial learning deficits of children with 
FASD will be necessary for years to come (Warren and Foudin, 1994).  
 
1.3Models of FASD 
The effects of alcohol during brain development have been extensively studied using 
animal models, and this large literature reveals the complexity of alcohol’s effects on the 
developing nervous system. Several themes have emerged. There are many mechanisms 
by which alcohol exerts its teratogenic effects and patterns of damage depend on the 
developmental timing, dose and pattern of alcohol administration (West et al., 1989, West 
and Hamre, 1985, Bonthius et al., 1988, Bonthius and West, 1990, West et al., 1990, 
Goodlett and Eilers, 1997, Goodlett and Johnson, 1997, Goodlett and Lundahl, 1996, 
Marcussen et al., 1994, Goodlett et al., 1989a, Olney et al., 2000, Olney et al., 2002a, 
Ikonomidou et al., 2000). 
 
1.3.1 Critical Periods of Vulnerability 
Toxicant exposure at different points in development can be harmful to an organ system. 
However, exposure that coincides with the emergence of cascades of developmental 
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processes are more likely to have adverse effects by altering delicately timed downstream 
processes (for review see: Rice and Barone, 2000). Development of the brain begins early 
in embryogenesis when the single-layered blastula develops the primitive streak, which 
establishes bilateral symmetry and the site of gastrulation. During gastrulation, the 
blastula reorganizes into the ectoderm, mesoderm and endoderm. Each of the three germ 
layers develops into specific tissues and organ systems in the embryo. The musculature, 
skeletal and circulatory system as well as the dermis and notochord are developed from 
the mesoderm. The digestive, respiratory system and epithelial tissues are formed from 
the endoderm. The ectoderm gives rise to the epidermis, neural crest and other cells that 
will eventually become the nervous system (for review see: Arnold and Robertson, 2009).  
At approximately two weeks human gestation, the notochord induces the 
overlying ectoderm to form the neural plate, which will become the brain and spinal cord. 
This process is known as neurulation. At approximately 18 days of gestation, the neural 
plate invaginates to form the neural groove with neural folds on either side. By the end of 
the third week, the neural folds are fusing together to form the neural tube. At this point, 
populations of cells have separated and begin to form the neural crest. The neural crest 
will become the sensory ganglia of cranial and spinal nerves, Schwann cells, as well as 
the meninges and muscular and skeletal components of the head. Neural tube formation is 
complete by gestational day 10.5 – 11 in rodents, which corresponds to the end of the 
first month of human gestation, a time when most pregnancies are first detected.  
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Figure 1.3.1 Comparative Brain Development Between Rodents and Humans. (Figure 
adapted from: Rice and Barone, 2000, and Winzer-Serhan, 2008)  
 
1.3.2 Alcohol Exposure During Early Development 
Alcohol exposure during gastrulation (G7 in mice; week three of human gestation) 
reliably induces holoprosencephaly, a condition in which the brain fails to form two 
distinct hemispheres, as well as ocular and midfacial deformities that mimic those 
necessary for a FAS diagnosis in children (Sulik and Johnston, 1982, Godin et al., 2010, 
Cook et al., 1987, Lipinski et al., 2012). Further study using this high-dose, binge alcohol 
exposure on G8 revealed increased incidence of hypoplasia or dysgenesis of the corpus 
callosum (Sulik, 1984), a finding often reported in human neuroimaging studies of those 
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exposed to alcohol gestationally (Mattson et al., 1996, Riley and McGee, 2005). These 
effects result from a very specific exposure on G7 within a three-hour time period in the 
mouse. The next several days of embryogenesis are associated with other developmental 
time point-specific effects corresponding with the end of the second through the sixth 
week of human fetal development.  
 
Alcohol exposure during the 8th day of gestation in mice (fourth gestational week in 
humans) was associated with extensive apoptosis along the neural crest, a portion of 
migratory cells forming most of the autonomic and peripheral nervous system. As this 
process occurs simultaneously with the development of the ectodermal formation, alcohol 
is likely altering craniofacial formation at this time (Dunty et al., 2001, Zhou et al., 2003). 
For this reason, midline craniofacial malformation has been proposed to be a reliable 
endophenotype of severe neurological dysfunction. Alcohol has also been reported to 
disrupt the retinoic acid signaling cascade, which plays a critical role in the 
morphogenetic processes of the embryo. As reviewed in Duester (1991), retinal is 
irreversibly oxidized by aldehyde dehydrogenase to retinoic acid, which in turn disrupts 
typical development by depleting retinoic acid stores. 
 
Alcohol has been shown to disrupt neurulation in a variety of ways. During the early 
stages of neurulation, G10-12, the neural plate thickens as a result of proliferation and 
migration of neuroepithelial cells. However, alcohol delays this process, resulting in 
increased perforation in and decreased size of the neural tube (Zhou et al., 2003). This 
disruption in normal neural tube development is likely directly related to the increased 
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ventricular size, decreased emergence of the serotonergic system and reduced neuronal 
cell number in humans and animals exposed to alcohol during gestation. As this 
perforation occurs along the midline of the neural tube, many midline neuroanatomical 
structures and facial features are affected by alcohol exposure during neurulation.  
 
1.3.3 Critical Periods of Vulnerability for Learning and Memory 
The last critical period of development is often referred to as the “brain growth spurt” 
which occurs from the 18th gestational day through the 9th day of rodent postnatal life, 
which neurodevelopmentally corresponds to the third trimester of human gestation (27-40 
weeks).  During this time, the brain undergoes rapid weight gain and proliferation of 
astroglia oligodendrocytes (Wiggins, 1982, Royland et al., 1993, Wiggins and Fuller, 
1978), synaptogenesis (Jacobson, 1991) and dendritic arborization (Rice and Barone, 
2000). During this the brain growth spurt, the hippocampus undergoes significant 
increases in proliferation of dentate gyrus granule cells, maturation of pyramidal cells of 
the Cornu Ammonis (CA)1 and CA3 fields, as well as increases in dendritic arborization, 
synaptogenesis and mylination leading to the formation of the forebrain circuitry 
necessary for learning and memory. One of the main principles of teratology is that organ 
systems are most vulnerable during the period of their most rapid growth and 
development. 
 
1.3.4 Postnatal Alcohol Exposure Models 
Alcohol exposure during the brain growth spurt results in reduced brain/body weight ratio 
(Tran et al., 2000), aberrant synaptogenesis, reactive gliosis (Goodlett et al., 1993, 
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Goodlett et al., 1997), delayed myelination (Lancaster et al., 1984), and cell loss in the 
hippocampus (Bonthius and West, 1990, Bonthius and West, 1991, Bonthius et al., 2001, 
Tran and Kelly, 2003, West and Hamre, 1985, West et al., 1986, West and Hodges-
Savola, 1983) and cerebellum (Borges and Lewis, 1983, Tran et al., 2005, Goodlett and 
Eilers, 1997, Goodlett and Lundahl, 1996, Goodlett et al., 1990, Goodlett et al., 1998, 
Goodlett et al., 1991, Green et al., 2006). Heavy binge-like alcohol exposure on P7 has 
been shown to produce dose-dependent apoptosis and enduring reductions in neuronal 
populations in several brain regions, including the cerebral cortex, hippocampal 
formation, anterior thalamus, mammillary bodies and cerebellum (Ikonomidou et al., 
2000, Tran and Kelly, 2003, West et al., 1990, Wozniak et al., 2004, Livy et al., 2003, 
Greene et al., 1992, Light et al., 2002a, Light et al., 2002b, Light et al., 1998).  
 
Olney and colleagues have extensively studied a rodent model of a single episode of 
binge alcohol exposure during the 3rd trimester equivalent using two subcutaneous 
injections of 2.5 g/kg alcohol, given two hours apart, producing peak blood alcohol 
concentrations (BACs) greater than 500 mg/dl and that remained above 200 mg/dl for 
more than six hours after the second injection (Ikonomidou et al., 2000, Olney et al., 
2002a, Wozniak et al., 2004). This alcohol exposure has been shown to induce epigenetic 
changes, increasing H3K9 and H3K27 dimethylation, by activating the histone 
methyltransferase G9a. Enhanced dimethylation of H3K9 and H3K27 leads to increases 
in neurodegeneration. Treatment with Bix, a G9a inhibitor, inhibited ethanol-induced 
enhancement of G9a expression and reversed associated neurodegeneration (Subbanna et 
al., 2013). In a number of studies since 1999, this model of extreme binge exposure has 
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been shown to cause a wave of apoptotic neurodegeneration, including activation of 
caspase-3, the appearance of TUNEL-positive cells and positive DeOlmos silver staining, 
in the cerebral cortex, hippocampal formation, retrosplenial cortex, mamillary bodies, 
anterior thalamic nuclei and basal ganglia (Wozniak et al., 2004, Ikonomidou et al., 2000, 
Olney et al., 2002a, Coleman et al., 2012, Ikonomidou et al., 1999, Wilson et al., 2011), 
with the largest effects elicited by treatment on P7.  In addition, the same alcohol-
treatment on P7 altered hippocampal functional connectivity in three-month-old adult 
C57BL/6 mice (Wilson et al., 2011), mimicking a hyperexcitability-like profile (Cortese 
et al., 1997, Slawecki et al., 2004) that may contribute to impaired spatial learning and 
memory. Binge alcohol exposure during this period also has been shown to result in a 
number of neurobehavioral deficits, including deficits in spatial learning and memory that 
can persist into adulthood in rats (Clements et al., 2005, Girard et al., 2000, Goodlett et 
al., 1989b, Johnson and Goodlett, 2002, Kelly et al., 1988, Pauli et al., 1995, Tomlinson 
et al., 1998, Wilson et al., 2011) and in C57BL/6 mice (Wozniak et al., 2004) and ddY 
outbred albino mice (Furumiya and Hashimoto, 2011).  
 
1.3.5 Modeling and Assessing Ethanol-Induced Changes in Spatial Learning 
Morris Water Maze 
The Morris water maze, developed in 1981 by Richard Morris, measures spatial learning 
and memory by allowing animals to locate a hidden platform using only distal room cues. 
Briefly, the procedure involves placing an animal into a large circular pool of water 
containing a submerged platform, obscured by opaque water. The animal is placed in the 
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pool facing the wall and allowed to swim to escape using the platform. The animal 
escapes the water by first swimming semi-randomly throughout the pool until the 
platform location is discovered. Over repeated trials, animals learn to use visuospatial 
cues to formulate a search strategy that allows them to find the platform more quickly 
(i.e., with reduced latency to escape) and directly (e.g., shorter path lengths to the 
platform; Eichenbaum et al., 1990, Morris, 1984, Morris et al., 1982, Morris, 1981).  
 
Developmental Alcohol Exposure and Spatial Learning 
Many brain regions are known to be important components of the neural systems 
underlying spatial navigation, learning and memory (e.g., hippocampal formation and 
entorhinal cortex; frontal, cingulate and parietal cortex; Morris et al., 1988, Morris et al., 
1982, Olton and Papas, 1979, Whitlock et al., 2008, Woolley et al., 2013, Kolb et al., 
1983). Ethanol exposures targeting the period of enhanced hippocampal vulnerability by 
administering alcohol from P7-9 (220-265 mg/dl) resulted in spatial learning deficits in 
juvenile Long-Evans rats (Goodlett and Johnson, 1997). As little as a single day of high-
dose alcohol exposure during the brain growth spurt has been shown to induce apoptotic 
neurodegeneration in the forebrain (Wozniak et al., 2004, Kumral et al., 2005, 
Ikonomidou et al., 2000) and produce massive spatial learning deficits in adolescent 
Wistar rats (Pauli et al., 1995) and C57BL/6 mice (Wozniak et al., 2004). In general, 
studies from several labs indicate that deficits on spatial learning resulting from alcohol 
exposure during the neonatal brain growth spurt require peak BACs that exceed 200 
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mg/dl (Ikonomidou et al., 2000, Tomlinson et al., 1998, Pauli et al., 1995, Wozniak et al., 
2004, Goodlett and Johnson, 1997).  
 
1.3.6 Summary 
Studying children with FASD can be informative, but with the variable exposures 
experienced by each exposed child, coupled with often-incomplete records of alcohol 
exposure, animal models are necessary to elucidate different mechanisms of alcohol-
induced damage to the fetus. Animal models of FASD have allowed the identification of 
critical periods of vulnerability during which some neural substrates are more susceptible 
to alcohol-induced damage. Understanding how alcohol influences development helps to 
design therapeutic intervention strategies to prevent damage or recovering functioning 
after the insult has occurred.  
 
1.4 Treatments Used to Ameliorate the Effects of Developmental Alcohol 
As with many neurodevelopmental disorders, treatments aimed at ameliorating the 
deficits seen as a function of fetal alcohol exposure can be behavioral or pharmacological 
in nature (Paley and O'Connor, 2011). There are currently no treatments for FASD 
approved by the Food and Drug Administration (FDA). In addition, the safety of 
pharmacological interventions aimed at preventing FASD during pregnancy has not been 
established. Therefore, all pharmacological interventions for these disorders are aimed at 
attenuating the symptoms typically discovered years after the initial alcohol exposure and 
don't necessarily treat the underlying neuropsychological issues.  
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1.4.1 Behavioral Interventions 
There have been many cognitive and behavioral interventions in schoolchildren with 
FASD that have shown promise. Kable and colleagues (2007) used a directed math 
intervention to significantly improve scores on math and the Archenbach child behavioral 
checklist. Similarly, Adnams and colleagues (2007) used a cognitive control therapy to 
increase academic performance as well as student confidence, motivation and efficacy. 
Rehearsal strategies have also been used to help children with FAS increase scores on 
digit span task (Loomes et al., 2008). Interestingly, these same strategies did not improve 
performance of control children. Other behavioral interventions directed at improving the 
motor dysfunction associated with FASD are only in their preliminary stages, but have 
shown promise. Behavioral interventions showing promise in the amelioration of the 
effects of fetal alcohol exposure in animals typically fall under the following three 
categories: environmental enrichment, voluntary exercise and complex motor learning. 
 
Environmental enrichment in animal models typically involves complex, stimulating 
housing conducive to locomotion, exploration and increases in social interactions among 
conspecifics (Reeves et al., 2007). Environmental enrichment has been shown to improve 
alcohol-induced spatial learning deficits (Wainwright et al., 1993, Hannigan et al., 1993), 
and normalize both alcohol-induced motor coordination deficits (Hannigan et al., 1993) 
and behavior in the open field (Zhou et al., 2007) without the typical neuroanatomical 
alterations associated with exposure to voluntary exercise (Berman et al., 1996, for 
review see: Markham and Greenough, 2004). Voluntary exercise on running wheels has 
been shown to improve alcohol-induced spatial learning deficits (Thomas et al., 2008, 
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Christie et al., 2005), normalize alcohol-induced hyperactivity and emotionality in the 
open field (Thomas et al., 2008), and enhance hippocampal capacity for sustained long-
term potentiation (Christie et al., 2005). Unlike environmental enrichment which failed to 
increase synaptic plasticity in alcohol-treated animals, wheel running promotes plasticity 
in rats given developmental alcohol exposure, namely increasing the proliferation and 
survival of newly generated neurons in the dentate gyrus (Redila et al., 2006, Boehme et 
al., 2011).  
 
In contrast to enriched environments and voluntary exercise paradigms, which involve 
varied exposure to sensory stimuli, motor activity and social interaction, complex motor 
learning requires mastery of specific sequences of complex movements to navigate 
obstacles designed to challenge cerebellar circuitry. Repeatedly forcing rats to traverse a 
set of ten elevated obstacles has been shown to stimulate cerebellar synaptogenesis in rats, 
specifically increasing parallel fiber-Purkinje cell synapses in the paramedian lobule of 
the cerebellum 25% in alcohol exposed offspring and normal controls (Klintsova et al., 
1997, Klintsova et al., 2002, Klintsova et al., 2000, Black et al., 1990). Complex motor 
learning was shown to normalize neonatal alcohol-induced performance deficits in tasks 
that challenge motor synchronization, increasing rope climbing ability and decreasing 
falls on the increasing speed version of the rotorod and parallel bars task (Klintsova et al., 
1998) and short-delay eyeblink classical conditioning (Wagner et al., 2013). These 
studies demonstrated that complex motor learning can stimulate synaptic morphological 
plasticity of surviving cerebellar neurons throughout adulthood and rehabilitate 
cerebellar-, but not yet tasks that depend on hippocampal integrity. 
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1.4.2 Pharmacological Manipulations 
To date, many pharmacological interventions have been designed to interfere with 
proposed mechanisms of alcohol’s teratogenesis (for review see: Goodlett et al., 2005, 
and Riley et al., 2001). This section outlines nutritional or otherwise pharmacological 
manipulations that have shown some success in alleviating or preventing alcohol-induced 
teratogenesis.  
Antioxidants and Dietary Supplements 
Work evaluating the effectiveness of dietary supplementation began in the 1980s after 
reports identified zinc deficiency in pregnant alcoholic women (Flynn et al., 1981). 
Shortly thereafter, dietary supplementation of zinc, glucose, nicotinamide adenine 
dinucleotide (NAD, or vitamin B3/niacin) in animal models of fetal alcohol exposure 
showed attenuation in alcohol-induced reductions in fetus and brain weight as well as 
protein content (Tanaka et al., 1982b, Tanaka et al., 1982a, Tanaka et al., 1983). 
Nicotinamide has been shown to successfully prevent P7 alcohol-induced caspase-3 
activation and cytochrome-c release and attenuated performance deficits in fear 
conditioning and normalized elevated plus maze and open field behavior (Ieraci and 
Herrera, 2006).  
 
Another antioxidant that has been evaluated for its potential to attenuate alcohol’s 
neurotoxicity during development is Vitamin C (ascorbic acid). Vitamin C has been 
shown to attenuate growth deficits and NF-kappa B activation in a Xenopus model of 
fetal alcohol exposure (Peng et al., 2005). Vitamin C also increased cell viability in part 
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by increasing the programed cell death inhibitor Bcl-2 and decreasing alcohol-induced 
increases in levels of proapoptitic Bax, which in turn decreased levels of cleaved caspase-
3 of cultured prenatal hippocampal neurons (Naseer et al., 2011). 
 
Vitamin E (α-Tocopheral) is known to function in the rat brain by reducing oxidative 
stress and protecting cell membranes from alcohol-induced lipid peroxidation by free 
radicals (Altura and Gebrewold, 1996, Halliwell, 1996) and influencing translocation of 
the proapoptotic protein Bax (Heaton et al., 2011). Vitamin E has been shown to increase 
viability of gestational hippocampal cells in culture (Mitchell et al., 1999) and protect 
against third-trimester equivalent alcohol-induced reductions in CA1 pyramidal cells, but 
not protect against the associated spatial learning impairments in rats (Marino et al., 2004) 
or cerebellar-mediated eyeblink conditioning deficits (Tran et al., 2005). 
 
Nearly 30 years of research has documented developmental alcohol-induced disruptions 
on the cholinergic system. In fact, high-dose, binge-like alcohol exposure on G7 in some 
cases completely ablated the septal region, which contains neurons that provide the 
primary cholinergic input to the hippocampus (Lewis et al., 1967). This treatment 
severely reduced the choline acetyltransferase immunostaining when examined one week 
later or just before birth (Schambra et al., 1990), or two weeks after birth, cholinergic 
immunostaining was shown to recover normal activity levels by the third week of 
postnatal life (Swanson et al., 1995). Conversely, alcohol-induced reductions in 
hippocampal muscarinic receptor number reductions remain present up to at least 90 days 
of postnatal life (Black et al., 1995).  Choline supplementation during the first three 
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weeks of life significantly improves discrimination learning with and without delay 
(Thomas et al., 2000). This improvement in functioning was not specific to the alcohol 
treatment group, but more of a general improvement in performance. However, this effect 
was so great in the alcohol-treated animals that there was no longer a significant 
difference between animals given alcohol and controls. Subsequent studies illustrated that 
postnatal choline, administered concurrently with alcohol exposure from P4-9 and 
continuing to adolescence ending on P30, significantly reversed neonatal alcohol-induced 
reductions in muscarinic M2/4, but not M1 receptor density in the hippocampus. This 
effect was associated with postnatal choline-attenuated alcohol-induced hyperactivity in 
the open field (Monk et al., 2012). Another exciting finding was that cholinergic 
supplementation was able to mitigate alcohol-induced deficits in the eyeblink 
conditioning. Interestingly, these improvements in this associative learning task were 
seen in the more complex, forebrain-dependent trace variant of this task, but not the more 
simple cerebellar-dependent short-delay training (Thomas and Tran, 2012). These 
findings, coupled with the lack of effects on alcohol-induced motor impairments (Thomas 
et al., 2004b), suggest that the choline supplementation is perhaps not having a global 
performance improvement, but is having a specific effect on the hippocampal cholinergic 
system. Clinical studies are currently underway to investigate the effects of choline 
supplementation on children with FASD. 
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“Ethanol Antagonists” 
Blocking Withdrawal-Evoked Excitotoxicity 
Alcohol is known to interact with the NMDA receptor (NMDAR), inhibiting its typical 
excitatory neurotransmission. Repeated or prolonged exposure can lead to adaptations 
such as increased number or sensitivity of receptors, leading to a state of 
hyperexcitability during alcohol withdrawal. This rebound hyperexcitability of NMDARs 
can contribute to seizure-like behavior and excitotoxic cell death (Lovinger, 1993). The 
NR2B subunit of the NMDAR-2 family are highly sensitive to alcohol and polyamines 
which are ubiquitious in development and enhance NMDAR activity (Williams et al., 
1994, Williams et al., 1991) and potentiate the alcohol withdrawal-induced cell death in 
vitro (Barron et al., 2008, Gibson et al., 2003). Blockade of NMDA receptors during 
alcohol withdrawal reduces alcohol-induced excitotoxic cell damage in culture (Lewis et 
al., 2012) and attenuates cognitive (Thomas et al., 2004a) and motor coordination (Lewis 
et al., 2007, Lewis et al., 2012, Idrus et al., 2011b, Idrus et al., 2011a) deficits as well as 
alcohol-induced hyperactivity (Lewis et al., 2012) in animal models of third trimester 
alcohol exposure. 
Serotonin Receptor Agonists 
Serotonin is an essential neurotrophic factor important for the modulation of growth cone 
elongation and neurite outgrowth, differentiation and synaptogenesis during brain 
development (Lauder, 1990). Alcohol exposure via a 25% alcohol-derived calorie diet 
beginning just prior to neurulation increased incidences of neural tube midline defects, 
including retardation of serotonergic (5-hydroxytriptamine [5-HT] synthesizing) neurite 
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outgrowth (Zhou et al., 2002, Zhou et al., 2005, Zhou et al., 2001, Zhou et al., 2003, Sari 
et al., 2001), compromising forebrain development along serotonergic pathways, and 
reducing the number of 5-HT reuptake sites in adult offspring (Kim and Druse, 1996). 
Concurrent treatment with 5-HT1A agonists prevented midline serotonergic neuronal 
depletion (Druse et al., 2004) and attenuated alcohol-induced reductions in pro-survival 
gene expression (Druse et al., 2006). 
Lithium 
Lithium has been shown to inhibit several pro-apoptotic pathways by directly inhibiting 
GSK3 and inositol monophosphatase in Xenopus oocytes (Subbanna et al., 2013). 
Lithium was subsequently found to be protective against P7 alcohol-induced apoptosis in 
C57BL/6 mice by preventing alcohol-induced inhibition of phosphorylation of ERK 
(Young et al., 2008), a pro-survival factor, and prevented alcohol induced down-
regulation of phosphorylated-AKT and –AMPK (Chakraborty et al., 2008), which can 
inhibit proapoptotic capacity of the protein BAD. 
Activity-Dependent Neuroprotective Peptides 
The neuroactive peptides NAPVSIPQ (NAP) and SALLRSIPA (SAL) are endogenous 
peptide fragments of activity dependent neurotrophic protein and activity dependent 
neurotrophic factor respectively. NAP and SAL are released from glia upon stimulation 
of the hop2 PAC-1 receptor on astrocytic membranes (Ashur-Fabian et al., 1997). These 
peptides are expressed in both the human and mouse central nervous system, 
predominantly in the cerebellum, hippocampus and cerebral cortex (Bassan et al., 1999) 
and have been shown to be neuroprotective against a variety of cellular stresses and 
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toxins in cell culture. Despite the widespread preclinical and clinical use of these peptides, 
data on bioavailability exists on relatively few routes of administration. For example, the 
bioavailability of NAP has been published in only intranasal and intravenous 
administration. When administered intranasally, NAP and SAL reach detecectable levels 
in the rat cortex at 30 and 60 minutes (Gozes et al., 2000). Intravenous NAP reaches the 
cortex and cerebellum of rats within 15 minutes and remains elevated for 60 minutes 
(Leker et al., 2002). NAP is vital for typical brain development. ADNP levels increase 
and remain elevated throughout the time of neural tube closure, G7.5-9. ADNP knockout 
mouse embryos exhibit failure of neural tube closure and die between G8.5 and 9 
(Pinhasov et al., 2003).  
 
In vivo studies have confirmed the neuroprotective properties of these peptides 
demonstrated in culture. For example, developmental NAP exposure prevents spatial 
learning deficits in adult apolipoprotein E-deficient mice (Brenneman et al., 2004, Bassan 
et al., 1999). Similarly, gestational treatment with NAP and SAL on G8-12 prevented 
spatial learning deficits (Incerti et al., 2012) and prevented some motor and sensory 
developmental delays (Toso et al., 2008) in Ts65Dn mice, a model of Down Syndrome. 
This treatment effect was found to be associated with normalized NR2A, NR2B and 
GABAA3 expression in 40-week-old adults (Vink et al., 2009). Gestational NAP and 
SAL have also been shown to protect against adult spatial learning deficits associated 
with alcohol-induced toxicity in animal models of FASD (Spong et al., 2001). 
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NAP has also been shown to prevent spatial learning deficits in adult rats resulting from 
hypoxic ischemia when administered up to 24 hours after the P7 insult (Greggio et al., 
2011). Likewise, NAP reduced mortality and neurological impairments in motor 
coordination, balance and alertness as early as 24 hours after trauma in adult mice when 
given subcutaneously within 15 minutes of traumatic brain injury (Beni-Adani et al., 
2001). Further, this NAP treatment regimen decreased expression of the adhesion 
molecule Mac-1, elevations of which are associated with severe neurological 
impairments in the same motor coordination battery (Romano et al., 2002, Gozes et al., 
2005).  
 
Chronic intranasal administration of NAP has been shown to rescue both spatial learning 
and novel object recognition deficits, and normalized hyperactivity resulting from the 
stable tubule-only polypeptide knock-out mouse model of schizophrenia (Gozes, 2011) 
and spatial learning deficits in choline-deficient adult rats (Gozes et al., 2000), an animal 
model of Alzheimer’s disease. Oral administration of NAP and SAL have been shown to 
be effective in completely reversing spatial learning deficits in mice given G8 heavy 
binge alcohol exposure when treatment was given in adulthood three days prior to and 
throughout water maze training (Incerti et al., 2010c). There are a number of purported 
mechanisms by which NAP and SAL are thought to have their protective effects against 
alcohol-induced toxicity.  
One mechanism is by antagonism of alcohol interactions with immunoglobulin L1 cell 
adhesion molecules (Wilkemeyer et al., 2000, Wilkemeyer et al., 2002). L1 cell adhesion 
molecules are transmembrane proteins that interact with neighboring cells to regulate 
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growth cone elongation, axonal pathfinding and fasciculation and neuronal migration 
through homophilic binding (Crossin and Krushel, 2000, Schmid et al., 2000). One 
theory was that perhaps NAP was able to induce neurite outgrowth in cerebellar granular 
neurons and antagonize alcohol-induced teratogenesis in mouse embryos by increasing 
L1 protein expression. However, NAP treatment failed to increase levels of L1 mRNA or 
protein expression in cerebellar granular neurons or astrocytes (Fitzgerald et al., 2011).  
 
NAP is typically shown to be more potent than SAL in neuroprotection assays in vivo 
(Bassan et al., 1999, Gozes et al., 2000, Spong et al., 2001). In fact, NAP has been shown 
to be significantly more potent than SAL at antagonizing the alcohol-induced inhibition 
of L1 cell adhesion molecules in human L1-transfected NIH/3T3 cells, although both 
NAP and SAL were effective at femtomolar and picomolar ranges, respectively, and have 
an unusually broad dose-response curve (Wilkemeyer et al., 2003). Additionally, the 
protective effects of SAL are reversible with increasing concentrations of alcohol 
(Wilkemeyer et al., 2002). NAP alone was able to prevent alcohol-antagonism of L1 cell 
adhesion molecules in 2A2-L1 cells, which are alcohol-sensitive subclones of NIH 3T3 
cells transfected with human L1 cDNA, at femtomolar doses and exert neuroprotection 
from TTX-induced cell death in astrocyte/neuronal co-cultures even in the picomolar 
range (Wilkemeyer et al., 2003). Even in whole embryo culture harvested at G8, 100pM 
NAP was sufficient to prevent 100mM alcohol-induced growth retardation (Wilkemeyer 
et al., 2003). Subsequent studies determined that co-incubating G8 embryos with 100mM 
alcohol and 100pM D-NAP, L-NAP or SAL could prevent neural tube closure defects 
(Chen et al., 2005). 
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Co-cultures of astrocytes and neurons from prenatal alcohol-exposed fetuses exhibit 
significantly reduced neuronal growth and differentiation as well as fewer synaptic 
contacts compared to control cultures. In addition, these prenatal alcohol-exposed 
cultures show marked reductions in levels of NAP mRNA (Pascual and Guerri, 2007). 
Adding NAP to the culture media was able to increase neuronal growth and stimulate 
synaptic connections, an effect that was reversed by inhibition of the mitogen-activated 
protein kinase. Inhibition of extracellular signal-related protein kinase (MAP/ERK), 
phosphatidylinositol-3-kinase (PI-3K)/Akt pathways and cAMP response element-
binding proteins (CREB) aborted the NAP-induced rescue of these cellular changes 
(Pascual and Guerri, 2007), revealing one mechanism by which NAP may be exerting its 
effects. Similarly, inhibiting sarcoma (Src) family kinases (SFK) and phosphorylation of 
Fyn kinase abolished NAP-induced axonal outgrowth in cultured cerebellar granule 
neurons (Chen and Charness, 2008). In fact, NAP was found to significantly increase 
phosphorylated Fyn kinase within 30 minutes of application. These increases of 
phosphorylated Fyn kinase lead to increases in phosphorylated Cas, a scaffolding protein 
necessary for axonal elongation. Ethanol potently inhibits NAP-mediated axonal 
elongation in these cell cultures by disrupting the Fyn kinase-Cas signaling cascade 
(Chen and Charness, 2008). 
SAL has been shown to increase nuclear factor- DNA binding in the hippocampal 
neurons (Glazner et al., 2000) and neurite extension via increases in CREB 
phosphorylation in dorsal root ganglia cultures (White et al., 2000). Prenatal 
administration of the less potent L-isoform of SAL has been shown to reduce alcohol-
induced, region-specific forebrain damage; particularly relevant to the current project are 
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the treatment-related increases in hippocampal and amygdalar volume in alcohol-treated 
offspring (Zhou et al., 2004). While some studies have shown these potent neuropeptides 
do not show chiral-specificity in antagonizing alcohol-inhibition of L1 cell adhesion 
molecules (Wilkemeyer et al., 2004), others have shown that the D-enantiomers of the 
peptides do not show the typical stereoisomeric ligand-receptor interaction, displaying 
greater potency in combating alcohol–induced growth restrictions and fetal demise than 
do their L-counterparts (Brenneman et al., 2004). Dietary D-SAL administration, 
concomitant with alcohol, significantly reduced alcohol-induced ocular abnormalities in 
C57Bl/6J mouse offspring (Parnell et al., 2007). One mechanism for this effect that has 
not yet been discussed are the interactions between Pax 6, a protein critical for ocular 
development, and L1 cell adhesion molecules (Meech et al., 1999, Chalepakis et al., 
1994). It is possible that by eliminating alcohol-inhibition of L1 cell adhesion, Pax 6 
signaling cascades proceed unmolested. This could account for the specificity in 
preventing alcohol-induced ocular abnormalities, while not affecting typical congenital 
ocular defects (Parnell et al., 2007). 
 
When given simultaneously with developmental alcohol exposure, the peptides (D-NAP 
and D-SAL) have been shown to antagonize alcohol-induced oxidative stress and 
inhibition of L1-mediated cell-cell adhesion molecules, important for proper neural tube 
closure (Spong et al., 2001, Wilkemeyer et al., 2002, Zhou et al., 2008). Combined 
treatment with D-NAP and D-SAL has proven to be most effective in the prevention of 
alcohol-induced fetal demise (Spong et al., 2001) and reduction of alcohol-induced 
deficits in spatial learning and memory in young adult offspring (Vink et al., 2005).  
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Particularly exciting were the recent findings by Incerti and colleagues (2010c) who 
showed that combined treatment with D-NAP and D-SAL, given orally beginning in late 
adolescence, three days prior to the initiation of and throughout the 7 days of water maze 
training, was able to completely reverse profound G8 alcohol-induced spatial learning 
deficits. Not only was this the first study to report profound spatial learning deficits 
following a single binge exposure to alcohol on G8, but it was the first study to show a 
peptide treatment effect well after the alcohol-induced insult had occurred. Other studies 
had shown the ability to reduce alcohol-induced weight restrictions and fetal demise 
when administered intraperitoneally three hours after alcohol administration, but this 
study administered 40µg of D-NAP and 40µg D-SAL more than one month after alcohol 
exposure to reverse a behavioral deficit. 
 
1.4.3 Summary 
Many treatments have been designed to prevent the damage caused by prenatal alcohol 
exposure. These preventative therapies have been successful in vitro and in animal 
models, and help us better understand mechanisms of alcohol-induced damage. However, 
given that FASD is 100% preventable and caused by alcohol use during pregnancy, 
treatments relying on compliance of an alcohol-abusing population may not always be 
effective. In addition, many children with FASD go unrecognized until well after the 
damage has occurred, when they reach school age. Treatments that can improve the lives 
of children and adults with FASD should be an important priority. Behavioral therapies 
like environmental enrichment, voluntary exercise and complex motor learning have 
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successfully ameliorated many of the deficits associated with FASD when administered 
in adolescence or adulthood. Historically, pharmacological therapies have targeted 
preventing alcohol-induced neurodegeneration, but over the past few years, treatments 
such as dietary choline supplementation and the activity-dependent neuropeptides have 
been shown to recover alcohol-induced learning deficits in animal models.  
 
1.5 Rationale 
While some pharmacological interventions given during pregnancy and aimed at 
reducing damage incurred during or shortly after alcohol exposure have shown promise 
(Incerti et al., 2010a, Incerti et al., 2010b, Toso et al., 2007, Wilkemeyer et al., 2003, 
Zhou et al., 2008, Zhou et al., 2004, Spong et al., 2001), treatment compliance among 
alcohol-abusing pregnant women is expected to be difficult (NIAAA, 2008) and 
pharmacotherapies during pregnancy may themselves carry risk for the fetus or the 
mother. Many children exposed to alcohol prenatally may have received inadequate 
prenatal care, and often are adopted into families that may not recognize the child’s brain 
damage and learning disabilities until they reach school age (Coles et al., 1991). 
Therefore, it is important to investigate treatments with potential to improve outcomes in 
children and adolescents already affected by prenatal alcohol-induced brain damage.  
Studies by Olney and colleagues using a P7 alcohol exposure in C57B/6 mice have 
provided neuropathological evidence of significant apoptosis and degeneration of post-
mitotic neuronal populations in specific layers of the cerebral cortex (frontal, cingulate, 
parietal, temporal, and retrosplenial cortex), hippocampal formation (CA1 and 
subiculum), striatum, anterior thalamus, and mammillary bodies (Olney et al., 2002b, 
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Wozniak et al., 2004). Previous work in our lab has confirmed that the profound spatial 
learning deficits shown in adolescent mice in the 2004 study by Wozniak and colleagues 
persist into adulthood (Wagner et al., submitted). Therefore, the significant spatial 
learning deficits produced by the P7 alcohol exposure in C57BL/6J mice yield an ideal 
model to extend the therapeutic benefit of oral administration of D-NAP and D-SAL 
shown to reverse spatial learning deficits when administered just three days prior to and 
throughout water maze training (Incerti et al., 2010c).  
 
1.5.1 Hypothesis 
Previous research dictates that high-dose, binge-like alcohol exposure (5g/kg) on P7 
would significantly impair spatial learning and memory in adult C57Bl/6J mice (Wagner 
et al., submitted). Based on the work of Incerti et al. (2010c), administration of 40g D-
NAP with 40g of D-SAL three days prior to and throughout water maze training (P67-
76) was hypothesized to significantly improve acquisition of place learning in the Morris 
water maze.  
 
Based on the work of Parnell et al. (2009) showing significant volumetric reductions in 
brain areas necessary for intact spatial learning and memory after two 2.8g/kg 
intraperitoneal alcohol injections separated by four hours on G8, and work by Incerti et al. 
(2010c) showing profound spatial learning deficits in late adolescent mice after a 5.8g/kg 
intraperitoneal alcohol injection on G8, the hypothesis was that the G8 alcohol 
administration protocol would induce significant spatial learning deficits in adult animals. 
Further, these spatial learning deficits could be reversed by oral administration of 40g 
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D-NAP with 40g of D-SAL three days prior to and throughout water maze training 
(P67-76).  
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CHAPTER 2 METHODS 
 
2.1 Subjects 
Eight-week old female C57BL/6J mice were purchased from Jackson Laboratories (Bar 
Harbor, ME) for use as breeders and housed in the Indiana University School of 
Medicine Biotechnology Research and Training Center vivarium. The vivarium was 
maintained on a 12h/12h light/dark cycle, lights on at 0900 hrs. For studies involving 
postnatal alcohol exposure, three cohorts of 12 female mice were ordered in waves 
approximately 3 weeks apart. Three male sires were also purchased from Jackson 
Laboratories with the original cohort of females. These sires were re-mated with all three 
cohorts of female mice until the postnatal studies were complete. Three cohorts of 16 
female mice were ordered in waves approximately 3 weeks apart. Four male sires were 
purchased for repeated matings with the 48 females used in the prenatal alcohol exposure 
studies. 
 
2.2 Animal Breeding 
Upon arrival, female mice were weighed, handled, and housed in breeding harems of four 
females. Animals were handled during the next 5-7 days during habituation to the facility. 
On mating days, female mice were placed into the cage of their designated male sire at 
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0700 hrs. Two hours later (0900 hrs; initiation of the light cycle) females were removed 
from the sire’s cage and examined for a sperm plug. Female mice without evidence of a 
sperm plug were retuned to their original cage to be re-mated the following morning at 
0700 hrs. Once determined to be sperm plug positive, designated G0, female mice were 
separated from their breeding harem and individually housed until her pups were weaned 
or until she was determined not to be pregnant. Mating was typically done over four to 
five consecutive days with three separate cohorts of mice, separated by approximately 
three weeks. Females failing to mate successfully within the four-day window were 
transferred to the subsequent cohort.  
 
2.3 Animal Husbandry 
 Once dams were determined to be sperm plug positive, they were single housed, handled 
and monitored for body weight on G0, 6, 8 10 and 15. Mice failing to exhibit significant 
weight gain by G15 were considered not pregnant and transferred to the next breeding 
cohort. Dams determined to be pregnant on G15 were placed in clean cages and started 
on wet feed to prepare for delivery on G19, also designated Postnatal Day (P) 0. Birth 
occurred on G19 for all litters used in these studies. Pregnant dams were not disturbed 
between G15 and 19 with the exception of the daily addition of wet feed.  
 
After pups were born, they were left undisturbed until P6 at which point all litters were 
culled to 6 pups, 3 male and 3 female when possible. Pups were given subcutaneous 
injections of very small quantities of non-toxic India ink into one or more paws to 
uniquely identify each pup in the litter. Litters of fewer than four pups were considered 
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non-viable, sacrificed and their dam returned to the pool of breeders for the next mating. 
Growth was monitored by measuring body weights of offspring on P6, 7, 10, 15, 21, and 
when weaned on P25. Pups were then allowed to mature until P64 at which point the 
offspring began daily handling and gavage habituation procedures to prepare for daily 
peptide intubations and behavioral testing. 
 
2.4 Alcohol Treatment 
2.4.1 Prenatal Alcohol Treatment 
Sulik Model 
Pregnant dams were randomly assigned to be given either intraperitoneal injections of 
alcohol in Ringer’s solution or only Ringer’s solution. Following the methods of Sulik et 
al. (1981), two intraperitoneal injections were administered on gestational day (G) 8, 4 
hours apart, of 2.9 g/kg alcohol (total dose of 5.8 g/kg) delivered as a 23.7% (v/v) alcohol 
solution in Ringer’s solution.  Injections were given in volumes of 0.015 ml/g of body 
weight on G8. Control dams were intraperitoneally injected with 0.015ml/g of 0.9% 
Ringer’s solution on the same schedule as alcohol-treated dams to account for the effects 
of injection stress on behavior. For this procedure pregnant dams were weighed for 
calculation of their alcohol injection volume and given their first injection (0900 hrs) and 
left undisturbed until their second injection (4 hours later).  
Webster Model 
Pregnant dams were randomly assigned to be given either intraperitoneal injections of 
alcohol in saline solution or only saline solution. Following the methods of Webster et al. 
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(1980) and Incerti et al. (2010c), 5.8 g/kg alcohol was delivered as a 25% (v/v) alcohol 
solution in 0.9% saline solution.  Injections were given in volumes of 0.03 ml/g of body 
weight on G8. Control dams were intraperitoneally injected with 0.03 ml/g of 0.9% saline 
solution on the same schedule as alcohol-treated dams to account for the effects of 
injection stress on behavior. For this procedure pregnant dams were weighed for 
calculation of their alcohol injection volume and given their first injection at 0900 hrs. 
 
2.4.2 Postnatal Alcohol Treatment 
Within each litter, pups were randomly assigned to receive twice daily injections of either 
alcohol (15% w/v in 0.9% w/v saline, 16.67ml/kg body weight) or physiological saline 
solution (0.9% w/v saline, 16.67ml/kg body weight) on P7. Injections were administered 
twice daily beginning between 0900-1100 hrs and again two hours after the first injection, 
as was reported in Wozniak et al. (2004). During the injection procedure all pups were 
removed from their dam, weighed and their injection volume calculated. Pups were then 
carefully injected subcutaneously at the nape of the neck. To ensure as little injection 
leakage as possible, the injection site was manipulated so that the needle could be 
pinched during it’s withdrawal from the injection site. Pups were then held for 15 to 20 
seconds to allow the injection volume to distribute and the injection site to better close. 
Pups were kept in a huddle on a 37ºC heating pad while other pups of that litter were 
manipulated. The injection procedure took approximately 10 minutes per litter, after 
which pups were returned to the home cage until time for the second injection. 
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2.5 Blood Alcohol Concentrations (BACs) 
Separate groups of mice were used for blood alcohol determination. After decapitation, 
trunk blood samples were collected in heparinized centrifuge tubes one, four and eight 
hours after the final alcohol injection. Samples were then centrifuged at 13,000 
revolutions per minute for 10 minutes, after which the plasma was extracted, sealed with 
parafilm to avoid evaporation and frozen at -20ºC for later analysis. BACs were assayed 
using an Analox® GL5 Alcohol Analyzer (Analox Instruments, Boston, MA), which uses 
alcohol oxidase to catalyze the oxidation of the alcohol in each sample to acetaldehyde 
and hydrogen peroxide. Because alcohol oxidase is specific to low molecular weight 
alcohols, the maximum rate of oxygen consumption is directly related to the alcohol 
concentration in a given sample.  
 
2.6 Peptide Treatment 
On P67, all offspring were treated with 40 g D-NAP [Biosynthesis, > 95% purity] and 
40 g D-SAL [Abbiotec, >90% purity] (200g of each peptide/ml) or vehicle (0.20 ml). 
Solutions were made from 10 mg D-SAL dissolved and diluted in 5 ml of filtered 
Dulbecco’s phosphate-buffered saline solution. 10 mg D-NAP were diluted in 0.5 ml of 
dimethyl sulfoxide and further diluted with the 4.5 ml of the filtered Dulbecco’s 
phosphate-buffered saline solution. This stock solution was diluted with filtered 
Dulbecco’s phosphate-buffered saline to reach the appropriate concentrations and then 
Alcohol Oxygen
Alcohol Oxidase
Alcetaldehyde Water+ +
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frozen in 1ml aliquots. A volume of 0.2 ml of this solution was administered via gavage 
between 0700 and 0900 hours for 11 days beginning on P67. 
 
2.7 Morris Water Maze 
2.7.1 Water Maze Procedure 
The offspring began training in the water maze at 70 days of age, three hours after 
peptide co-treatment, by an experimenter blind to alcohol and peptide treatment 
conditions. Training consisted of four acquisition trials each day for seven consecutive 
days in the Morris water maze. During each training trial, mice were given 60 seconds to 
navigate a 125cm (diameter) pool filled to within 25cm of the rim of the tank with 26°C 
water made opaque by adding non-toxic white tempera paint (Dick Blick Art Materials, 
Galesburg IL) in which a 9cm (diameter) platform was placed. The top of the submerged 
platform was 0.5cm below the surface of the water rendering it invisible to the test 
subject. The pool rested on top of a 12” stand made of cinder blocks. The testing 
environment (280 X 390cm), illuminated by indirect incandescent lighting, contained 
fixed audio (radio kept at low volume) and visual reference cues (e.g. posters, mobile, 
sink, computer, and experimenter). The platform position remained constant throughout 
training, with each squad randomly assigned a platform position. Throughout trials, mice 
learn to use the distal room cues to locate the escape platform. As training progressed 
shorter escape path lengths and decreased latencies to find the hidden platform were used 
as indices of spatial learning.  
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A probe trial, administered after the last acquisition trial on day 7 of training, was used to 
examine each animal’s search strategy. During probe trials, subjects were given 60 
seconds to navigate the pool without the presence of the escape platform, while the 
escape path was monitored. Each trial, including the probe, was initiated by introducing 
the animal to the pool (facing the wall) at one of 8 starting positions (corresponding to the 
8 cardinal directions) and lasted until the animal mounted the platform or 60 seconds had 
expired. Different, pseudo-randomly determined, starting points were used for each trial. 
Mice were not started within the same quadrant as the target, nor were start positions 
repeated on a given day.  
 
If a mouse was unable to find the platform, it was guided to the platform by the 
experimenter. All subjects remained on the platform for 10 seconds before being returned 
to their respective incubators (30±1°C), used to limit hypothermia during the intertrial 
interval. Mice were tested in squads of 3 or 4, resulting in an intertrial interval of 
approximately three minutes. At the end of each day of testing, the mice were allowed to 
remain in the incubators until warm and mostly dry (approximately 10 minutes) before 
being returned to the vivarium. 
 
2.7.2 Water Maze Data Collection 
Escape paths were monitored by a video camera interfaced with computer-controlled 
tracking software (HVS Image, Hampton, UK) and recorded by a JVC VCR. The 
computer-controlled tracking software displayed the moment-to-moment position of the 
animal in the pool. Dependent variables assessed by this software included escape latency, 
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escape path length, swim speed, initial heading angle and time spent in thigmotaxis 
(swimming the perimeter of the pool). 
 
During probe trials, the computerized video tracking system superimposed virtual 
counting discs (27cm, i.e., three times the size of the platform) over the pool in the 
location of the animal’s designated platform position. The video tracking software 
obtained measures of time spent in, latency to enter, and numbers of passes through the 
target virtual counting disc; these measures were used to quantify the spatial distribution 
of the search strategy of each animal.  
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CHAPTER 3 POSTNATAL ALCOHOL RESULTS 
 
3.1 Blood Alcohol Concentrations 
The mean BACs on P7 are shown in Table 3.1. The mean (±SEM) BAC on P7, one hour 
after the second alcohol injection, was 472 (±16) mg/dl. The alcohol clearance rate, 
calculated using the values obtained at 4 and 7 hours after the second alcohol injection, 
was 27.7 mg/dl/hr (Table 1). Substantially higher than BACs Kelly and colleagues 
(1987a, peak 411 mg/dl ) reported to disrupt typical sensory and motor development. 
 
Table 3.1.1 Blood Alcohol Concentrations from trunk blood samples taken at 1, 4 and 7 
hours after the final alcohol injection. 
1 Hour 4 Hours 7 hours 
472 ±16 385 ±8 302 ±13 
n = 13 n = 12 n = 11 
 
 
3.2 Body Weight Analysis 
As shown in Figure 3.2.1, all mice gained weight during the early postnatal and pre-
weaning period [main effect of day F(4,344) = 4019.9, p<0.005], with males weighing 
significantly more than females [day X sex interaction: F(4,344) = 2.85, p<0.05]. Alcohol 
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treatments on P7 resulted in a significant body weight deficit during the pre-weaning 
period [day X alcohol treatment interaction: F(4,344) = 6.40, p<0.005].  
 
Figure 3.2.1 Offspring body weights. Open circles represent animals given saline on P7 
closed squares represent mice given alcohol on P7. The bar graph separates mice further 
into their peptide treatment group. From left to right and dark to light the groups are P7 
saline – vehicle; P7 saline – peptide; P7 alcohol – vehicle; P7 alcohol – peptide. 
indicates p<0.05 
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Looking at each sex separately, females gained weight over the pre-weaning period as 
expected [main effect of day: F(4,180) = 2724.0, p<0.005]; however, alcohol treatment 
on P7 caused a significant delay in body weight gain [main effect of alcohol treatment: 
F(1,45) = 7.02, p<0.05; day X alcohol treatment interaction: F(4,180) = 5.65, p<0.005]. 
This effect persisted through weaning on P25 until the end of behavioral testing on P77 
[main effect of alcohol treatment on P25: F(1,45) = 9.18, P<0.005; main effect of alcohol 
treatment on P67: F(1,45) = 15.07, p<0.005; main effect of alcohol treatment on P77 
F(1,45) = 18.89, p<0.005]. There were no peptide treatment effects on body weights at 
any time. In contrast, males only showed alcohol treatment effects on body weight on 
P67 [main effect of alcohol treatment: F(1,41) = 4.48, p<0.05], when alcohol-treated 
mice weighed 0.969g less than their saline-treated controls (p<0.05). As was the case 
with female mice, there were never any peptide-treatment effects in bodyweights. 
 
3.3 Morris Water Maze Acquisition 
All offspring improved performance in the water maze task over time by decreasing the 
average path length swum to escape over days [Figure 3.3.1; main effect of day: F(6,516) 
= 67.10, p<0.005]; however, this improvement was impaired by alcohol exposure on P7 
[main effect of alcohol F(1,86) = 33.33, p>0.005; alcohol treatment X day interaction 
F(6,516) = 2.49, p<0.05]. Performance was also found to be sex dependent, as males 
decreased escape path lengths faster than females and ended with lower terminal 
performances [main effect of sex F(1,86) = 8.74, p<0.005]. To investigate well-
established sex differences in water maze learning, males and females were subsequently 
analyzed separately. 
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Figure 3.3.1 Morris Water Maze Acquisition. Panel A&C illustrate acquisition rates of 
each group over testing days, while B&D show performance collapsed over the last three 
days of training (separated by sex; females Panel A&C, males Panels B&D). Circles 
indicate mice given saline on P7. Squares represent mice given alcohol on P7. Open 
symbols represent animals given vehicle in the post-weaning period. Closed symbols 
represent mice given peptide. In Panels B&D from left to right and dark to light the 
groups are P7 saline – vehicle; P7 saline – peptide; P7 alcohol – vehicle; P7 alcohol – 
peptide. indicates p<0.05 
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Females 
Females improved performance over the course of training indicated by shorter path 
lengths to reach the escape platform [Figure 3.3.1 A&C; main effect of day: F(6,270) = 
27.23, p<0.005]. Alcohol exposure on P7 impaired water maze acquisition [F(1,45) = 
14.78, p<0.005]. Within females, there were no main or interactive effects of post-
weaning peptide treatment. 
Males 
Males also improved performance over training days showing shorter escape path lengths 
across training [Figure 3.3.1 B&D; main effect of day F(6,246) = 41.14, p<0.005]. P7 
alcohol exposure induced a deficit in acquisition [main effect of alcohol treatment F(1,41) 
= 19.62, p<0.005; alcohol treatment X day interaction F(6,246) = 2.82, p<0.05]. Within 
males, there were no main or interactive effects of post-weaning peptide treatment. 
 
3.4 Water Maze Probe 
3.4.1 Time Spent in the Target vs Non-Target Platform Regions 
Seven days of water maze training significantly increased the amount of time spent 
searching virtual counting area three times the size of the platform superimposed over the 
region of the pool that previously contained the platform compared to the average time 
spent in three equally sized regions superimposed in three other parts of the pool [main 
effect of pool region: F(1,59) = 117.76, p<0.005]. The preference for the target region of 
the pool was significantly decreased by P7 alcohol exposure [main effect of P7 alcohol 
treatment: F(1,59) = 15.03, p<0.005, P7 alcohol treatment x pool region interaction: 
F(1,59) = 15.15, p<0.005]. Female mice spent significantly less time in the target region 
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vs the average non-target regions than males [sex X pool region interaction: F(1,59) = 
4.61, p<0.05]. 
 
Figure 3.4.1 Time Spent in the Target vs. Non-Target Regions of the Pool. From left to 
right and dark to light the groups are P7 saline – vehicle; P7 saline – peptide; P7 alcohol 
– vehicle; P7 alcohol – peptide. Solid bars represent time spent in the target while 
hatched bars represent time spent in an average of the three non-target platform 
regions.indicates p<0.05 
 
Females 
Seven days of water maze training led to a significant preference for the target platform 
region [Figure 3.4.1A; main effect of pool region: F(1,32) = 43.33, p<0.005], spending 
more time in that region during probe trials than the average time spent in the other three 
non-target regions. Alcohol treatment on P7 did disrupt the preference for the target 
region [main effect of P7 alcohol treatment: F(1,32) = 9.84, p<0.005; P7 alcohol 
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treatment X pool region interaction: F(1,32) = 8.59, p<0.01]. Alcohol-treated animals 
given peptide treatment tended to prefer the target vs non-target platform more than 
alcohol-treated females given vehicle, but it failed to reach significance [F(1,32) = 3.30, 
p=0.079]. 
Males 
Males also preferred the target platform region over the non-target region after 7 days of 
water maze training [Figure 3.4.1B; F(1,27) = 73.87, p<0.005]. Alcohol treatment on P7 
disrupted this preference [main effect of P7 alcohol treatment: F(1,27) = 5.73, p<0.05; P7 
alcohol treatment X pool region interaction F(1,27) = 6.68, p<0.05], yielding a less 
organized search strategy. There were no main or interactive effects of post-weaning 
peptide co-treatment. 
3.4.2 Passes Through the Target vs Non-Target Platform Regions 
After 7 days of water maze training, all mice showed a preference for the region of the 
pool that contained the escape platform, illustrated by an increase in the number of times 
the mice passed through the superimposed target region vs. an average of three 
identically sized regions in other portions of the pool [main effect of pool region: F(1,59) 
= 107.8, p<0.005]. Alcohol treatment on P7 significantly impaired preference for the 
target platform region, decreasing the number of passes through the target region 
compared to the three other non-target regions [main effect of P7 alcohol treatment: 
F(1,59) = 8.81, p<0.005; P7 alcohol treatment X pool region interaction: F(1,59) = 8.22, 
p<0.01]. Performance on this measure was also found to be dependent on sex and peptide 
treatment such that peptide treatment significantly increased the number of passes 
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through the target platform region of alcohol treated female mice [P7 alcohol treatment X 
peptide co-treatment X sex X pool region interaction: F(1,59) = 4.12, p<0.05; P7 alcohol 
treatment X peptide co-treatment X sex interaction: F(1,59) = 6.45, p<0.05]. 
Figure 3.4.2 Number of Passes Through Target vs. Non-Target Regions of the Pool. 
From left to right and dark to light the groups are P7 saline – vehicle; P7 saline – peptide; 
P7 alcohol – vehicle; P7 alcohol – peptide. Solid bars represent time spent in the target 
while hatched bars represent time spent in an average of the three non-target platform 
regions.indicates p<0.05  
 
Females 
Female mice made more passes through the target vs an average of the other three non-
target platform regions [Figure 3.4.2A; main effect of region type: F(1,32) = 53.50, 
p<0.005]. Alcohol treatment on P7 significantly decreased the number of passes through 
the target vs non-target platform regions [main effect of P7 alcohol treatment: F(1,32) = 
10.91, p<0.005; P7 alcohol treatment X region type interaction: F(1,32) = 7.62, p<0.01]. 
There was a trend toward an interaction between P7 alcohol treatment, post-weaning 
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peptide treatment and region type due to the modest increases in passes through the target 
region in mice given P7 alcohol treatment, while those given saline on P7 did not 
improve [P7 alcohol treatment X peptide co-treatment X region type interaction F(1,32) 
= 3.23, p=0.082; P7 alcohol treatment X post-weaning peptide treatment interaction: 
F(1,32) = 3.37, p=0.076]. 
Males 
Male mice also preferred the target to an average of the non-target regions of the pool 
[Figure 3.4.2B; F(1,27) = 52.96, p<0.005]. P7 alcohol treatment did not significantly 
reduce the number of passes through the target vs the non-target platform region. There 
was a trend toward an interaction between P7 alcohol treatment and post-weaning peptide 
treatment on the preference for the target region due to the slight peptide-induced 
impairment in P7 alcohol-treated mice, while mice given saline on P7 saw slight 
increases in the number of passes through the target vs non-target platform regions [P7 
alcohol treatment x post-weaning peptide treatment interaction: F(1,27) = 3.15, p=0.087]. 
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CHAPTER 4PRENATAL ALCOHOL SULIK MODEL RESULTS 
4.1 Blood Alcohol Concentrations 
The mean BACs on G8 are shown in Figure 4.1. The mean (±SEM) BAC on G8 after the 
first alcohol injection was 297 (±23) mg/dl at 30 minutes, and declined to 243 (±29) 
mg/dl at one hour, 134 (±22) mg/dl at 2.5 hours and 72 (±16) mg/dl at the time of the 
second injection. The next peak came 30 minutes after the second alcohol injection, was 
481 (±30) mg/dl and then declined to 461 (±27) mg/dl at one hour, 417 (±27) mg/dl at 90 
minutes and 370 (±28) at the last measurement two hours after the final alcohol injection. 
The alcohol clearance rate, calculated using the values obtained at 1 and 2 hours after the 
second alcohol injection to be 91.9 mg/dl/hr (Figure 4.1.1).  
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Figure 4.1.1 Blood Alcohol Concentrations. Tail bloods taken from 15 separate pregnant 
dams at 8 days gestation. The arrow indicates the time point of the second alcohol dose 
(2.8g/kg in Ringer’s solution) 
 
4.2Body Weight Analysis 
Body weights of all pregnant dams were measured on the day of sperm plug G0, 6, 8, 10 
and 15. All pregnant dams gained weight over the gestational period as expected [Figure 
4.2.1; main effect of day: F(4,104) = 1346.47, p<0.005] although the pattern of weight 
gain over the gestational period depended on gestational treatment [day X treatment 
interaction: F(4,104) = 2.95, p<0.05]. Narrowing the analysis to the two gestational data 
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points after the alcohol treatment reveals that these differences in weight gain are not a 
function of the gestational alcohol treatment as only the main effect of day remains 
significant [F(1,26) = 1452.07, p<0.005].  
 
Figure 4.2.1 Pregnant Dam Body Weights. Open circles represent dams given saline on 
G8 closed squares represent dams given alcohol on G8.   
 
Weights of offspring were measured on P6, 7, 10, 15, 21 and at weaning on P25. All 
offspring gained significant amounts of weight during the neonatal and early postnatal 
period [main effect of day: F(5,260) = 481.71, p<0.005] an effect that depended on sex as 
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males gained weight faster than females [day X sex interaction: F(5,260) = 2.39, p<0.05]. 
All female offspring gained weight throughout this period [Figure 4.2.2 A; main effect of 
day: F(5,130) = 238.58, p<0.005] an effect that gestational alcohol exposure did not alter. 
Male offspring showed the same pattern of weight gain increasing over the neonatal and 
early postnatal period [Figure 4.2.2 C; main effect of day: F(5,130) = 244.90, p<0.005]. 
Animal weights just before the initiation of the peptide co-treatment on P67 revealed only 
a main effect of sex [Figure 4.2.2 B&D; F(1,50) = 28.57, p<0.005], but no effect of 
gestational alcohol exposure on G8. Analysis of body weights after water maze training 
on P77 also showed only the expected main effect of sex [F(1,137) = 512.63, p<0.005] 
with no effects of either E8 alcohol exposure or the peptide co-treatment on P67 - 76. 
  
58 
5
8
 
 
Figure 4.2.2 Offspring body weights. Open circles represent offspring of mice given 
saline on G8 closed squares represent offspring of mice given alcohol on G8. The bar 
graph separates mice further into their peptide treatment group. From left to right and 
dark to light the groups are G8 Ringer’s – vehicle; G8 Ringer’s – peptide; G8 alcohol – 
vehicle; G8 alcohol – peptide. 
 
4.3 Morris Water Maze Acquisition 
All offspring were able to increase water maze performance decreasing average path 
lengths swum to escape over training days [Figure 4.3.1; main effect of day F(6,432) = 
93.40, p<0.005]. There were no main or interactive effects of G8 alcohol treatment, pre-
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training co-peptide treatment or sex. As sex differences are often present in measures of 
spatial learning and memory, each sex was be evaluated separately to ensure differences 
aren’t disguised by other performance measures. 
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Figure 4.3.1 Morris Water Maze Acquisition. Panel A&C illustrate acquisition rates of each 
group over testing days, while B&D show performance collapsed over the last three days of 
training (separated by sex; females Panel A&C, males Panels B&D). Circles indicate offspring of 
mice given saline on G8. Squares represent offspring of mice given alcohol on G8. Open symbols 
represent animals given vehicle in the post-weaning period. Closed symbols represent mice given 
peptide. In Panels B&D from left to right and dark to light the groups are G8 Ringer’s – vehicle; 
G8 Ringer’s – peptide; G8 alcohol – vehicle; G8 alcohol – peptide.   
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Females 
Post hoc analyses revealed only the expected main effect of day [Figure 4.3.1A; F(6,264) 
= 49.61, p<0.005], illustrating that all female offspring were able to acquire the task 
regardless of pre-training co-peptide treatment. 
Males 
The same patterns were shown in male offspring with only the expected main effect of 
day [Figure 4.3.1C; F(6,264) = 52.71, p<0.005] reaching significance. 
4.4 Water Maze Probe 
There were no differences in performance measures during the probe trials such as path 
length swum, swimming speed or time spent in thigmotaxis. 
 
4.4.1 Time Spent in the Target vs Non-Target Platform Regions 
All offspring given 7 days of water maze training spent more time in the target platform 
region of the pool compared to the average time spent in the other three non-target 
platform regions of the pool [Figure 4.4.1; F(1,88) = 100.49, p<0.005], an effect that did 
not depend on gestational alcohol treatment on G8 or peptide co-treatment.  
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Figure 4.4.1 Time Spent in the Target vs. Non-Target Regions of the Pool. From left to 
right and dark to light the groups are G8 Ringer’s – vehicle; G8 Ringer’s  – peptide; G8 
alcohol – vehicle; G8 alcohol – peptide. Solid bars represent time spent in the target 
while hatched bars represent time spent in an average of the three non-target platform 
regions. 
Females 
Female offspring preferred the former platform-containing region to the average of the 
other three non-platform regions [Figure 4.4.1A; main effect of pool region: F(1,44) = 
43.46, p<0.005]. This preference was not affected by gestational alcohol treatment on G8 
or the peptide co-treatment. 
Males 
Male offspring also preferred the region of the pool that previously contained the 
platform over an average of the other three non-platform containing regions [Figure 
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4.4.1B; main effect of pool region: F(1,44) = 57.00, p<0.005], an effect that was not 
affected by alcohol exposure on G8 or peptide co-treatment group. 
 
4.4.2 Passes Through the Target vs Non-Target Platform Regions 
Similar patterns of performance were seen when evaluating the number of passes made 
through the region of the pool that had formerly contained the platform region compared 
to the average of the other three regions of the pool that had never contained the escape 
platform [Figure 4.4.2; main effect of pool region F(1,65) = 212.74, p<0.005]. This 
performance measure was also not affected by sex, gestational alcohol exposure on G8 or 
peptide co-treatment group.   
 
Figure 4.4.2 Number of Passes Through Target vs. Non-Target Regions of the Pool. 
From left to right and dark to light the groups are G8 Ringer’s – vehicle; G8 Ringer’s – 
peptide; G8 alcohol – vehicle; G8 alcohol – peptide. Solid bars represent time spent in the 
target while hatched bars represent time spent in an average of the three non-target 
platform regions. 
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Females 
Female offspring showed similar performance, making more passes through the platform 
region that formerly contained the platform than the average number of passes through 
the other three regions of the pool [Figure 4.4.2A; main effect of pool region: F(1,33) = 
108.94, p<0.005]. 
Males 
Male offspring also made more passes through the region of the pool that had contained 
the platform compared to the average number of passes through the regions of the pool 
that had never contained the platform [Figure 4.4.2B; main effect of pool region: F(1,32) 
= 103.95, p<0.005].
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CHAPTER 5 PRENATAL ALCOHOL WEBSTER MODEL RESULTS 
5.1 Blood Alcohol Concentrations 
The mean BACs on G8 are shown in Figure 5.1. The mean (±SEM) BAC on G8 after the 
alcohol injection was 731 (±22) mg/dl at 30 minutes, and declined to 656 (±12) mg/dl at 
one hour, 602 (±11) mg/dl at 1.5 hours and 557 (±14) mg/dl at two hours after the alcohol 
injection. The alcohol clearance rate, calculated using the values obtained at 1 and 2 
hours after the second alcohol injection to be 99.1 mg/dl/hr (Figure 5.1.1). 
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Figure 5.1.1 Blood Alcohol Concentrations. Tail bloods taken from 18 separate pregnant 
dams at 8 days gestation. 
 
 
5.2Body Weight Analysis 
Body weights of all pregnant dams were measured on the day of sperm plug G0, 6, 8, 10 
and 15. All pregnant dams gained weight over the gestational period as expected [Figure 
5.2.1; main effect of day: F(4,72) = 49.74, p<0.005]. In contrast to the Sulik alcohol 
exposure model there were no effects of alcohol exposure on G8 on maternal weight gain. 
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Narrowing the analysis to the two gestational data points after the alcohol treatment 
confirms gestational weight gain was not dependent on the gestational alcohol treatment 
as only the main effect of day remains significant [F(1,18) = 35.85, p<0.005].  
 
Figure 5.2.1 Pregnant Dam Body Weights. Open circles represent dams given saline on 
G8 closed squares represent dams given alcohol on G8. 
 
Weights of offspring were measured on P6, 7, 10, 15, 21 and at weaning on P25. All 
offspring gained significant amounts of weight during the neonatal and early postnatal 
period [Figure 5.2.2; main effect of day: F(5,175) = 1542.83, p<0.005] Males gained 
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weight more rapidly than females [day X sex interaction: F(5,175) = 11.15, p<0.005] and 
G8 alcohol exposure delayed weight gain [day X alcohol treatment interaction: F(5,175) 
= 2.41, p<0.05] . All female offspring gained weight throughout this period [Figure 
5.2.2A; main effect of day: F(5,80) = 505.21, p<0.005], an effect that gestational alcohol 
exposure did not alter. Male offspring showed the same pattern of weight gain increasing 
over the neonatal and early postnatal period [Figure 5.2.1B; main effect of day: F(5,95) = 
1189.46, p<0.005]. Body weights just before the initiation of the peptide co-treatment on 
P67 were not affected by G8 alcohol exposure. Analysis of body weights after water 
maze training on P77 also showed no effects of either G8 alcohol exposure or the peptide 
co-treatment on P67 - 76. 
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Figure 5.2.2 Offspring body weights. Open circles represent offspring of mice given 
saline on G8 closed squares represent offspring of mice given alcohol on G8. The bar 
graph separates mice further into their peptide treatment group. From left to right and 
dark to light the groups are G8 saline – vehicle; G8 saline – peptide; G8 alcohol – vehicle; 
G8 alcohol – peptide. 
 
5.3 Morris Water Maze Acquisition 
Males 
All mice showed the typical performance improvement over the seven days of training 
illustrated by the expected main effect of day [Figure 5.3.1A; F(6,234) = 33.78, p<0.005]. 
  
70 
7
0
 
While there were no main effects of G8 alcohol treatment or pre-training peptide co-
treatment, analyses revealed a significant interaction of G8 alcohol exposure and peptide 
treatment over days [alcohol treatment X pre-training peptide co-treatment x day 
interaction F(6,234) = 2.23, p<0.05. Subsequent analyses yielded no further two way 
interactions, therefore, the three way interaction was driven by the change in groups over 
days not effects of either the alcohol treatment or peptide treatment on performance. A 
chi-square test of independence was performed to examine whether peptide treatment 
improved water maze acquisition in animals given alcohol treatment on G8. The criteria 
for acquisition was set as having an average path length of 5 meters or less on each day of 
training. There was no significant relationship between water maze acquisition in 
alcohol-treated animals as a function of peptide treatment on any testing day, or when 
collapsed over the first three days of training, as shown in figure 5.3.1b.  
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Figure 5.3.1 Morris Water Maze Acquisition. Panel A illustrates acquisition rates of each 
group over testing days, while B shows the number of mice meeting the 5m path length 
criteria over the first three days. C shows performance collapsed over the last three days 
of training. Circles indicate offspring of mice given saline on G8. Squares represent 
offspring of mice given alcohol on G8. Open symbols represent animals given vehicle in 
the post-weaning period. Closed symbols represent mice given peptide. In Panel B and C 
from left to right and dark to light the groups are G8 saline – vehicle; G8 saline – peptide; 
G8 alcohol – vehicle; G8 alcohol – peptide. 
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5.4 Water Maze Probe 
There were no differences in performance measures during the probe trials, such as path 
length swum, swimming speed or time spent in thigmotaxis. 
 
Figure 5.4.1 Probe Performance Panel A Time Spent in the Target vs. Non-Target 
Regions of the Pool. Panel B Number of Passes Through Target vs. Non-Target Regions 
of the Pool. Solid bars represent time spent in the target while hatched bars represent time 
spent in an average of the three non-target platform regions. From left to right and dark to 
light the groups are G8 saline – vehicle; G8 saline – peptide; G8 alcohol – vehicle; G8 
alcohol – peptide. 
 
5.4.1 Time Spent in the Target vs Non-Target Platform Regions 
Males 
After 7 days of water maze training all animals spent significantly more time in the 
region of the pool that had contained the escape platform [Figure 5.4.1A; main effect of 
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pool region: F(1,39) = 86.40, p<0.005]. This preference was affected by neither alcohol 
treatment on G8 nor the peptide co-treatment.  
 
5.4.2 Passes Through the Target vs Non-Target Platform Regions 
Males 
Likewise all mice passed through the target platform region significantly more times than 
the average number of passes through the other three regions that never contained the 
platform [Figure 5.4.1B; main effect of pool region: F(1,39) = 67.71, p<0.005]. Passes 
through the platform region was also not affected by either G8 alcohol exposure or 
peptide co-treatment. 
  
74 
7
4
 
CHAPTER 6. DISCUSSION 
6.1 Overall Summary 
The primary objectives of the present experiments were to evaluate the therapeutic 
potential of the activity-dependent neuropeptides D-NAP and D-SAL in rescuing alcohol-
induced deficits in the acquisition of spatial learning and memory. Herein it is reported 
that a single episode of a high-dose, binge-like alcohol exposure on P7 induces spatial 
learning deficits that persist into adulthood. These findings replicate previous reports that 
high-dose, binge-like alcohol exposure on P7 produces significant acquisition and 
retention deficits in Morris water maze learning in adult C57BL/6 mice (Wagner et al., 
submitted, Furumiya and Hashimoto, 2011). Peptide treatment with 40µg D-NAP and 
40µg D-SAL did not have any effect on spatial learning in this model of FASD.  
 
Surprisingly, neither model of a single episode of a high-dose, binge-like alcohol 
exposure on G8 produced significant learning deficits in the Morris water maze, even 
though the maternal peak BACs produced by the two models were very high (481 mg/dl 
for the Sulik model and 731mg/dl for the Webster model). The lack of effect in the latter 
case meant that this study failed to replicate the key previous study on which the current 
study was based, i.e., the study by Incerti et al. (2010c) that reported very large 
acquisition deficits with the same gestational treatment. Of course, the lack of a learning 
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deficit induced by the gestational alcohol treatment precluded the ability to determine 
peptide treatment effects. These findings underscore the need for confirmation of brain 
malformations due to the alcohol treatment, as there is thus far, no positive control to 
verify that the alcohol treatment had any effects. Tissues have been collected, but their 
analysis was outside the scope of this thesis.  
 
6.2 Potential reasons for failure to replicate Incerti et al. (2010c) 
Neither the Sulik nor the Webster model of alcohol exposure was able to replicate the 
spatial learning deficits found in the Incerti et al. (2010c) study. One major difference 
between the current studies and the Incerti et al. (2010c) study are the ages that Morris 
water maze testing occurred. Incerti et al. (2010c) tested their mice starting at P43, 
however, the current study sought to test animals that were through adolescence and well 
into adulthood (P70). Choosing to test animals in adulthood ensures animals are not 
experiencing a developmental delay in their spatial learning abilities, but, in fact, have 
enduring impairments, as a result of their developmental alcohol exposure.  
 
Incerti and colleagues (2010c) do not report the diameter of the water maze used in their 
study. An earlier study from the same lab (Endres et al., 2005) reports using an 80cm 
diameter Morris water maze pool. The pool used in the current study was 126 cm in 
diameter. This size difference results in two and a half times the amount of searchable 
surface area, which would lead to a much more challenging task for the animals in the 
current study. In addition to having a smaller pool, mice in the Incerti et al. (2010) study 
were given two consecutive trials each day compared to four trials per day in this study. 
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Consecutive trials or ‘massed practice’ has been shown to produce slower acquisition 
than ‘distributed practice’ in the Morris water maze, suggesting a post trial rest period is 
necessary for acquisition of water maze place learning (Hasegawa et al., 1988, Commins 
et al., 2003). While the exact trial time was not reported, one can glean that the maximum 
trial time was 60 seconds based on the y-axis of the acquisition graph. The authors also 
fail to report the intertrial interval in which the animal is left on the platform. Previous 
reports from this lab have allowed mice 15 seconds on top of the platform before being 
placed in the pool for each trial, except for the first day when the mice are allowed 60 
seconds before the trial begins (Endres et al., 2005). It is not clear from the methods of 
the Incerti et al. (2010c) paper if these are the methods used, but they are the most similar 
to those published by the same lab in other reports. Despite these methodological 
differences, control mice in the current study showed nearly identical terminal 
performance to control mice of the Incerti et al. (2010c) study; therefore, the differences 
in alcohol effects between the two studies can not be explained by differences in general 
performance or task parameters. 
 
Another possibility for failure to replicate the peptide-treatment effect in our neonatal 
alcohol-treatment group could be the source of the peptides. The Incerti study does not 
report the source or purity of the peptides used in their study. The peptides D-NAP and 
D-SAL were obtained from Bio-Synthesis, Inc. and ABBIOTEC, respectively. Both 
peptide sources guaranteed products were >95% purity by high performance liquid 
chromatography and mass spectrometry analysis. There are no reports on the long-term 
stability of this peptide, thus great care was taken to ensure quality and viability. All 
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peptides were stored at -20ºC until prepared for gavage treatments. Fresh peptide 
solutions were prepared before each cohort began treatment. The peptide solutions were 
aliquotted and stored at -20ºC until the morning they were to be used. Once thawed, 
peptide solution was never refrozen, but was stored in a 4ºC refrigerator for use the next 
morning. A study by Brenneman and colleagues (1998), which discusses a steep decrease 
in bioavailability of SAL after even one freeaze-thaw cycle, had been overlooked until 
final revision of this thesis. Although, SAL is known to be the least potent and 
efficacious of the two peptides used, it is uncertain as to whether the lack of significant 
effects of the peptide treatments in this study and the differences between this study and 
that of Incerti and colleagues (2010c) can be fully explained by the decreased 
bioavailability of D-SAL. Further, this error could only account for differences in the 
peptide effect and cannot explain the lack of alcohol effects on water maze learning. 
Experiment 3 with the Webster model was intended to serve as a positive control, but 
since there were no significant alcohol- or peptide-treatment effects, the current studies 
have no positive control. However, given the guaranteed quality and careful handling of 
the peptides, it is unlikely that they were inactive. 
 
The neuropeptides NAP and SAL are able to protect against alcohol-induced 
neurodegeneration when administered with or just following alcohol administration. 
Although not much is known about their upstream or downstream effects, recent work 
has determined that NAP and SAL exert their neuroprotective effects in part by 
interfering with proapoptotic and inducing antiapoptotic cytokines and chemokines 
(Roberson et al., 2012, Zamostiano et al., 1999), preventing mitochondrial accumulation 
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of reactive oxygen species (Glazner et al., 1999), and promoting axonal elongation 
(Smith-Swintosky et al., 2005) and synapse formation (Blondel et al., 2000). Other 
studies illustrating NAP- and SAL-induced increases in hippocampal cell density 
(Kumral et al., 2006) gave promise to the rehabilitative potential of these neuropeptides, 
but in studies showing these promising results, the treatment is either applied just after 
the inflammation event, or during a period in which the brain is already in a very plastic 
state.  
 
Perhaps the lack of a peptide-treatment effect in the postnatal study could be indicative of 
a critical window for peptide treatment exposure, rather than an inability to recover 
spatial learning as measured by the Morris water maze. For example, alcohol exposure on 
G8, producing peak BACs of 381mg/dl (Parnell et al., 2009), has been shown to disrupt 
development of the neural plate (Sulik and Johnston, 1983, Sulik et al., 1981, Sulik et al., 
1984), producing volumetric reductions in olfactory bulbs, hippocampus and septal 
regions, as well as the cerebellum and pituitary gland (Parnell et al., 2009). It is possible 
that the peptide treatment interacts with these damaged neural substrates in a particular 
way during adolescence that increases the functional integrity of systems necessary for 
spatial learning and memory. It is possible that adolescence is a critical period for 
influencing synaptic plasticity in brains that have undergone this particular type of 
damage that results in significant hippocampal cell loss and that peptide treatments given 
during this time period are able to integrate the surviving cells into a more functional 
network. While there is no evidence for NAP and SAL inducing hippocampal LTP, there 
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is evidence for NAP potentiating alcohol-induced inhibition synaptic plasticity through 
its interactions with the NMDA receptor (Zhang et al., 2005).  
 
Given the lack of an alcohol treatment effect in the current study using the Sulik model, 
the final aim of this thesis was to replicate the alcohol treatment paradigm used by Incerti 
et al. (2010c) with the expectation that the most severe alcohol administration of a 
5.8g/kg bolus on G8 could produce a spatial learning deficit that would allow the peptide 
co-treatment effects to be adequately evaluated. However, despite producing “heroic” 
(and near toxic) peak BACs of 730mg/dl on G8, this model surprisingly failed to produce 
a significant deficit in Morris water maze acquisition in the young adult male C57BL/6 
mice. Therefore, the effects of the peptide co-treatment on G8 alcohol-induced learning 
deficits could not be evaluated in this study. Although the peak BACs reached in the 
current study are approximately 91% of that reported by the Webster and colleagues 
(1980), from whom Incerti modeled their exposure, it is implausible that a spatial 
learning deficit could have been elicited from a G8 treatment with peak BACs of 
800mg/dl, but not a similar one with peak BACs of 730mg/dl. There have been decades 
of work illustrating a timing- and does-dependent relationship between developmental 
alcohol exposure and its detrimental effects, but those studies generally evaluate 
differences in effects with doses ranging between 50 and 400mg/dl. The BACs generated 
in all of the current experiments are well above any that have been evaluated as 
“threshold” doses for hippocampal neurotoxicity or behavioral dysfunction (Goodlett and 
Johnson, 1997, Hunt et al., 2009, West et al., 1990, West et al., 1987, Ikonomidou et al., 
2000).  
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It should be noted that all of the aforementioned studies that evaluated hippocampal 
neurotoxic or behavioral thresholds were evaluated using one form or another of third-
trimester equivalent exposure. Incerti et al. (2010c) appear to be the first to report deficits 
in Morris water maze acquisition after a G8 alcohol exposure, but they were not the first 
to investigate the effects of this exposure on spatial learning and memory. Minetti and 
colleagues (1996) failed to show water maze acquisition deficits in both 45- and 90-day 
old rats that had been exposed to a Sulik-style alcohol exposure on G8 that produced 
BACs of 457mg/dl 60 minutes after the second alcohol injection.  
 
Our findings are consistent with many reports of spatial learning and memory deficits 
induced by high-dose alcohol insults during the third trimester equivalent (Furumiya and 
Hashimoto, 2011, Goodlett and Peterson, 1995, Johnson and Goodlett, 2002, Pauli et al., 
1995, Tomlinson et al., 1998, Goodlett and Johnson, 1997). Our previous study of P7 
binge-like exposure in C57BL6 mice – that formed the basis for the current test of the 
neuroprotective peptides in the neonatal alcohol exposure model – showed that the 
single-day, binge-like alcohol exposure on P7 induced significant spatial learning deficits 
in adulthood, supporting it as an excellent model by which to assess the therapeutic 
potential of the activity-dependent, neuroprotective peptide co-treatment. The current 
results failed to confirm (in P70 adults) the rescue effects of the peptide treatment 
reported for (P40 late adolescents) by Incerti et al., (2010c). In our hands, the 40µg D-
NAP plus 40µg D-SAL administered three days prior to and throughout Morris water 
maze training failed to influence spatial learning and memory deficits induced by P7 
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alcohol exposure in our version of the Morris water maze task. Due to the laborious and 
costly nature of this protocol, a dose-response peptide treatment was determined to be 
prohibitively expensive. However, it is possible, especially given the freeze-thaw related 
decrease in bioavailability of SAL, that the doses of peptides were insufficient to rescue 
such severe spatial learning deficits.  
 
The results of the Incerti et al. (2010c) study were interesting and exciting to say the least. 
No other pharmacological studies have shown such a successful recovery of functioning 
after such a devastating developmental, alcohol-induced learning deficit. At this point, 
pharmacotherapeutic interventions have been more successful in the attenuation or 
prevention of developmental alcohol-induced neurobiological and behavioral dysfunction 
when administered concurrently with the alcohol treatment, whether the insult occurs 
gestationally or in the early postnatal period. The antioxidant/vitamin work is a great 
example of this concept. The antioxidants exert their effects against alcohol-induced 
apoptosis by scavenging the excessive reactive oxygen species, which are agents that 
cause activation of the apoptosis cascades. The antioxidant mechanisms of 
neuroprotection are, therefore, most beneficial during an inflammation event, such as 
binge-like alcohol exposure, when there are reactive oxygen species being produced. As 
such, administration of antioxidants after the damage has already occurred would be 
expected to have little or no effect. While the work on choline supplementation seems to 
suggest that co-administration with the alcohol insult is helpful in the reversal of alcohol-
induced behavioral and neurobiological disruptions, the fact that choline supplementation 
has a more global effect on learning, increasing performance of controls as well as 
  
82 
8
2
 
alcohol-exposed animals, suggests that it may not be necessary that the choline 
supplementation be administered at the time of the alcohol insult. However, the choline 
supplementation in these studies was all administered during a time when the brain is 
very plastic. Future studies are needed to examine the potential of choline 
supplementation when administered later in life in the reversal of developmental alcohol-
induced learning deficits.  
 
Other more classic pharmacotherapies, such as drugs that inhibit NMDAR 
hyperexcitability in response to alcohol withdrawal (Gibson et al., 2003, Lewis et al., 
2012) and 5HT1A agonists– which in culture have been shown to stimulate astrocytic 
release of trophic support (Eriksen and Druse, 2001) thereby preventing alcohol-induced 
cell loss (Tajuddin and Druse, 1999) – have shown therapeutic potential, but could have 
potentially dangerous consequences if administered in vivo due to the important role both 
serotonin and NMDA play in the migration, synaptogenesis and organogenesis during 
gestational and perinatal development (Zhou et al., 2002, Xu et al., 2004, Zhou et al., 
2005, Xiao et al., 2013).  
 
Finally, behavioral therapies have shown promise in the rehabilitation of a variety of 
alcohol–induced learning deficits. Importantly, behavioral therapies investigated in the 
treatment of alcohol-induced behavioral and neurological dysfunction have been shown 
to be effective long after the alcohol-induced damage has occurred. Environmental 
enrichment and voluntary exercise are both able to stimulate neurogenesis (Hamilton et 
al., 2012), improve alcohol-induced motor coordination deficits (Klintsova et al., 1997, 
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Munn et al., 2011), normalize alcohol-induced hyperactivity (Thomas et al., 2008), and 
improve alcohol-induced spatial learning deficits (Berman and Hannigan, 2000, Thomas 
et al., 2008). This profile of benefits makes these interventions well suited for the 
treatment of damage induced by alcohol at any point in development. In contrast, 
acrobatic motor learning has been shown to increase cerebellar synaptogenesis (Klintsova 
et al., 2000) and improve alcohol-induced deficits in motor performance (Klintsova et al., 
2000, Klintsova et al., 1998) and cerebellar-dependent eyeblink classical conditioning 
(Wagner et al., 2013), but have not yet been shown to improve deficits in hippocampal-
dependent tasks induced by alcohol exposure during the third trimester equivalent. 
Therefore, acrobatic motor learning is well suited for treatment of a third trimester 
alcohol insult, but would be best used in combination with environmental enrichment, 
voluntary exercise or choline supplementation. 
 
Although behavioral therapies and choline supplementation have shown promise, it’s 
important to pursue the therapeutic potential of activity-dependent neuroprotective 
peptides. These peptides are able to limit damage induced by alcohol, and in at least one 
report (Incerti et al., 2010c), completely recover gestational alcohol-induced deficits in 
adult offspring. The lack of a positive control in the current studies means it is too early 
to close the book on the rehabilitative potential of the activity dependent neuropeptides 
D-NAP and D-SAL. First, NAP and SAL should be tested against a reliable spatial 
learning deficit in adolescent mice to determine whether the peptide treatment is more 
effective during adolescence and why. If adolescence is a critical period for 
synaptogenesis, which drove the success in the Incerti et al. (2010c) study, the peptide 
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treatment should be successful in correcting the spatial learning deficit resulting from a 
postnatal alcohol insult. Because the G8 alcohol insult was unable to produce a deficit by 
which to test the peptide treatment, the next logical step would be to increase task 
demands by adding reversal, which has purportedly been able to elucidate subtle deficits 
in spatial learning following a G8 alcohol exposure (Wieczorek et al., 2013). If both of 
these experiments fail to confirm the peptide effect of Incerti et al. (2010c), I think the 
route of administration of the peptide should be changed. Whereas oral administration 
does have its translational flare, administration via an intraperitoneal injection or 
intranasally could ensure enough of the peptide is getting to the brain to be efficacious. 
However, given the lack of bioavailability data from these routes of administration this 
idea is a generalization based on the routes of administration of drugs in general. If the 
peptide treatment can be shown to be successful in reversing spatial learning deficits, it 
will be important to determine if this effect generalizes to other tests of spatial learning 
and memory and then finally to other tests of hippocampal-dependent functioning that are 
independent of spatial processing. 
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APPENDIX  
A.1 Postnatal Alcohol Acquisition 
A 2 (alcohol treatment) x 2 (peptide treatment) x 2 (sex) x 7 (day) repeated 
measures ANOVA revealed that all offspring improved performance in the water maze 
task over time by decreasing the average latency to escape over days [Figure A.1.1; main 
effect of day: F(6,516) = 56.95, p<0.005]; however, this improvement was impaired by 
alcohol exposure on P7 [main effect of alcohol F(1,86) = 26.88, p>0.005]. Unlike path 
length performance only tended to be sex dependent, as males decreased escape path 
lengths faster than females and ended with lower terminal performances [main effect of 
sex F(1,86) = 2.95, p=0.089]. A 2 (alcohol treatment) x 2 (peptide treatment) x 2 (sex) x 
7 (day) repeated measures ANOVA revealed that changes in swimming speed over 
training days depended on both alcohol treatment and sex [main effect of alcohol 
treatment: F(1,86) = 9.52, p<0.005; alcohol treatment x day interaction: F(6,516) = 4.28, 
p<0.005; alcohol treatment x sex x day interaction: F(6,516) = 2.61, p<0.05]. As shown 
in figure A.1.2, a 2 (alcohol treatment) x 2 (peptide treatment) x 7 (day) repeated 
measures ANOVA revealed that Male animals given saline during the neonatal period 
swam faster than those given alcohol in the neonatal period [main effect of alcohol: 
F(1,41) = 5.00, p<0.005; alcohol x day interaction F(6,246) = 6.57, p<0.005]. 
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Figure A.1.1 Morris Water Maze Acquisition Mean Latency to Escape. Circles indicate 
mice given saline on P7. Squares represent mice given alcohol on P7. Open symbols 
represent animals given vehicle in the post-weaning period. Closed symbols represent 
mice given peptide.  
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Figure A.1.2 Morris Water Maze Swimming Speed During Acquisition. Circles indicate 
mice given saline on P7. Squares represent mice given alcohol on P7. Open symbols 
represent animals given vehicle in the post-weaning period. Closed symbols represent 
mice given peptide.  
 
A.2 Sulik Model Acquisition 
A 2 (alcohol treatment) x 2 (peptide treatment) x 2 (sex) x 7 (day) repeated 
measures ANOVA revealed that all offspring improved performance in the water maze 
task over time by decreasing the average latency to escape over days [Figure A.2.1; main 
effect of day: F(6,528) = 84.62, p<0.005]; an effect that was in no way influenced by 
alcohol exposure on G8 or peptide treatment during the training period. A 2 (alcohol 
treatment) x 2 (peptide treatment) x 2 (sex) x 7 (day) repeated measures ANOVA 
revealed that changes in swimming speed over training days depended on both alcohol 
treatment and sex [main effect of alcohol treatment: F(1,86) = 9.52, p<0.005; alcohol 
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treatment x day interaction: F(6,516) = 4.28, p<0.005; alcohol treatment x sex x day 
interaction: F(6,516) = 2.61, p<0.05]. As shown in figure A.2.2, swimming speed was 
influenced by a combination of factors. Specifically, throughout training, mice given 
alcohol treatment swam significantly slower than those given Ringer’s solution on G8 
[main effect of alcohol treatment: F(1,88) = 4.18, p<0.05] an effect that was also found to 
be dependent on peptide treatment and sex [alcohol treatment x peptide treatment x sex 
interaction: F(1,88) = 14.23, p<0.005]. A 2 (alcohol treatment) x 2 (peptide treatment) x 
7 (day) repeated measures ANOVA confirmed that this effect was driven by the fact that 
female mice given alcohol on G8 and then given vehicle intubations during the training 
period swam significantly slower than all other groups [alcohol treatment x peptide 
treatment interaction: F(1,44) = 5.37, p<0.05]. 
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Figure A.2.1 Sulik Model Morris Water Maze Acquisition Mean Latency to Escape. 
Circles indicate mice given Ringer’s Solution on G8. Squares represent mice given 
alcohol on G8. Open symbols represent animals given vehicle in the post-weaning period. 
Closed symbols represent mice given peptide.  
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Figure A.2.2 Sulik Model Morris Water Maze Swimming Speed During Acquisition. 
Circles indicate mice given Ringer’s solution on G8. Squares represent mice given 
alcohol on G8. Open symbols represent animals given vehicle in the post-weaning period. 
Closed symbols represent mice given peptide.  
 
A.3 Webster Model Acquisition 
A 2 (alcohol treatment) x 2 (peptide treatment) x 7 (day) repeated measures 
ANOVA revealed that all offspring improved performance in the water maze task over 
time by decreasing the average latency to escape over days [Figure A.3.1; main effect of 
day: F(6,234) = 1.67, p<0.005]; an effect that was in no way influenced by alcohol 
exposure on G8 or peptide treatment during the training period. A 2 (alcohol treatment) x 
2 (peptide treatment) x 7 (day) repeated measures ANOVA revealed that all animals 
increased swimming speed over the course of training [main effect of day: F(6,234) = 
5.16, p<0.005]. However, alcohol animals swam slower over the course of training 
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compared to controls [alcohol treatment x day interaction: F(6,234) = 2.86, p<0.05; 
figure A.3.2].  
 
Figure A.3.1 Webster Model Morris Water Maze Acquisition Mean Latency to Escape. 
Circles indicate mice given saline on G8. Squares represent mice given alcohol on G8. 
Open symbols represent animals given vehicle in the post-weaning period. Closed 
symbols represent mice given peptide.  
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Figure A.3.2 Webster Model Morris Water Maze Swimming Speed During Acquisition. 
Circles indicate mice given saline on G8. Squares represent mice given alcohol on G8. 
Open symbols represent animals given vehicle in the post-weaning period. Closed 
symbols represent mice given peptide.  
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